{
  "candidates": [
    {
      "ticker": "LRCX",
      "sector": "Information Technology",
      "theme": null,
      "factor_scores": {
        "value": 0.4666666666666667,
        "quality": 1.0,
        "growth": 1.0,
        "stability": -0.5,
        "revisions": 0.7428571428571429,
        "momentum": 0.040043837464170826
      },
      "sentiment": {
        "overall_sentiment": "bullish",
        "sentiment_score": 0.75,
        "analyst_consensus": "Buy",
        "analyst_score": 0.7,
        "news_sentiment": "bullish",
        "news_score": 0.8,
        "key_drivers": [
          "Strong analyst recommendations with a consensus of 64.3% Buy",
          "Positive news sentiment with multiple bullish headlines",
          "Recent price increase attributed to favorable market conditions"
        ],
        "key_risks": [
          "Potential volatility around upcoming earnings report",
          "Market sensitivity to AI and tariff-related news",
          "Overall market conditions affecting tech stocks"
        ],
        "price_target_upside": 2.9481779893792335
      },
      "risk_flags": {
        "passed_all_checks": true,
        "failed_checks": [],
        "liquidity_ok": true,
        "price_ok": true,
        "no_trading_halts": true,
        "no_pending_ma": true,
        "earnings_clear": true
      },
      "composite_score": 0.6496392757069107,
      "news_summary": "Lam Research (LRCX) is gaining attention ahead of its upcoming earnings report on January 28, 2026, with analysts optimistic about its potential to beat estimates due to a strong earnings surprise history. The stock has recently risen by 5.0%, driven by positive sentiment surrounding AI-related semiconductor spending and concerns over U.S. tariffs impacting chip equipment demand. Additionally, LRCX has been added to the Zacks Rank #1 (Strong Buy) List, indicating strong market confidence. Despite some underperformance compared to competitors, the overall outlook remains positive as the company continues to be recognized for its leadership in the semiconductor supply chain.",
      "price": 218.44,
      "market_cap": 274367193200.0,
      "scored_at": "2026-01-23T11:28:43.735322"
    },
    {
      "ticker": "KGC",
      "sector": "Materials",
      "theme": "Geopolitical Risk and Safe Havens",
      "factor_scores": {
        "value": 0.9,
        "quality": 0.85,
        "growth": 1.0,
        "stability": 0.1,
        "revisions": 0.8692307692307693,
        "momentum": 0.963659147869674
      },
      "sentiment": {
        "overall_sentiment": "bullish",
        "sentiment_score": 0.8,
        "analyst_consensus": "Buy",
        "analyst_score": 0.76,
        "news_sentiment": "bullish",
        "news_score": 0.6,
        "key_drivers": [
          "Strong analyst consensus with 76.9% Buy recommendations",
          "Positive news coverage highlighting growth and project updates",
          "High RSI indicating strong momentum"
        ],
        "key_risks": [
          "Potential market volatility affecting gold prices",
          "Dependence on successful project execution in the U.S.",
          "High current price relative to historical performance"
        ],
        "price_target_upside": -10.500067394527553
      },
      "risk_flags": {
        "passed_all_checks": true,
        "failed_checks": [],
        "liquidity_ok": true,
        "price_ok": true,
        "no_trading_halts": true,
        "no_pending_ma": true,
        "earnings_clear": true
      },
      "composite_score": 0.6262914612538673,
      "news_summary": "Kinross Gold Corporation (KGC) has been actively updating its U.S. projects, including significant developments at Round Mountain Phase X and Kettle River-Curlew, as discussed in recent presentations. UBS and Bank of America have expressed bullish sentiments towards KGC, with UBS raising its price target from $31 to $33, highlighting the company's strong position in the gold market as it enters 2026. Overall, the gold mining sector is experiencing optimism following a strong performance in 2025, with KGC being recognized as one of the top gold mining companies to invest in now.",
      "price": 37.095,
      "market_cap": 45349514426.0,
      "scored_at": "2026-01-23T11:31:11.323457"
    },
    {
      "ticker": "NEM",
      "sector": "Materials",
      "theme": "Geopolitical Risk and Safe Havens",
      "factor_scores": {
        "value": 0.7999999999999999,
        "quality": 0.7,
        "growth": 1.0,
        "stability": 0.7,
        "revisions": 0.9,
        "momentum": 0.6690891048653067
      },
      "sentiment": {
        "overall_sentiment": "bullish",
        "sentiment_score": 0.8,
        "analyst_consensus": "Buy",
        "analyst_score": 0.8,
        "news_sentiment": "bullish",
        "news_score": 0.8,
        "key_drivers": [
          "Strong analyst consensus with 80% Buy recommendations",
          "Positive news regarding gold prices and company performance",
          "High RSI indicating strong momentum"
        ],
        "key_risks": [
          "Current price significantly above SMA20 and SMA50, indicating potential overbought conditions",
          "Market volatility affecting gold prices",
          "Dependence on gold market trends"
        ],
        "price_target_upside": -14.432669718532996
      },
      "risk_flags": {
        "passed_all_checks": true,
        "failed_checks": [],
        "liquidity_ok": true,
        "price_ok": true,
        "no_trading_halts": true,
        "no_pending_ma": true,
        "earnings_clear": true
      },
      "composite_score": 0.6175756716602525,
      "news_summary": "Newmont Corporation (NEM) has experienced significant share price momentum, with a 36.7% increase over the past three months and a year-to-date return of 17.5%. This surge is largely attributed to rising gold prices, which recently spiked to nearly $5,000 an ounce amid geopolitical tensions. Analysts have rated NEM as a Strong Buy, highlighting its robust profitability and favorable market conditions for gold and copper. Additionally, an upcoming earnings report is expected to further influence investor sentiment and potential returns on the stock.",
      "price": 123.3999,
      "market_cap": 134661745287.0,
      "scored_at": "2026-01-23T11:30:20.069768"
    },
    {
      "ticker": "MRK",
      "sector": "Health Care",
      "theme": null,
      "factor_scores": {
        "value": 0.7999999999999999,
        "quality": 0.85,
        "growth": 0.2,
        "stability": 0.7,
        "revisions": 0.6555555555555556,
        "momentum": -0.24706377098915563
      },
      "sentiment": {
        "overall_sentiment": "bullish",
        "sentiment_score": 0.6,
        "analyst_consensus": "Buy",
        "analyst_score": 0.5,
        "news_sentiment": "bullish",
        "news_score": 0.6,
        "key_drivers": [
          "Strong analyst consensus with 55.6% Buy recommendations",
          "Positive news regarding personalized cancer therapy and oncology drugs",
          "Recent price performance above key moving averages (SMA20 and SMA50)"
        ],
        "key_risks": [
          "Bearish news regarding potential competition and patent issues",
          "Market volatility affecting overall sector performance",
          "Dependence on successful drug pipeline outcomes"
        ],
        "price_target_upside": 10.19575099730958
      },
      "risk_flags": {
        "passed_all_checks": true,
        "failed_checks": [],
        "liquidity_ok": true,
        "price_ok": true,
        "no_trading_halts": true,
        "no_pending_ma": true,
        "earnings_clear": true
      },
      "composite_score": 0.5959070161962835,
      "news_summary": "Merck (MRK) has recently entered a multi-year partnership with Guardant Health to enhance its oncology drug development and sales efforts, signaling a strategic move to bolster its cancer treatment portfolio. Additionally, promising data from a collaboration with Moderna on a personalized cancer therapy has shown a significant reduction in recurrence or death risk for high-risk melanoma patients. As the pharmaceutical landscape faces patent cliffs, similar to those experienced by AbbVie, Merck's focus on innovative therapies may be crucial for sustaining growth amid competitive pressures.",
      "price": 107.79,
      "market_cap": 269236058458.0,
      "scored_at": "2026-01-23T11:26:08.251034"
    },
    {
      "ticker": "GOOGL",
      "sector": "Communication Services",
      "theme": "AI Infrastructure Buildout",
      "factor_scores": {
        "value": 0.4666666666666667,
        "quality": 1.0,
        "growth": 0.5,
        "stability": 0.1,
        "revisions": 0.903921568627451,
        "momentum": -0.12094827413506302
      },
      "sentiment": {
        "overall_sentiment": "bullish",
        "sentiment_score": 0.6,
        "analyst_consensus": "Buy",
        "analyst_score": 0.8,
        "news_sentiment": "bearish",
        "news_score": -0.2,
        "key_drivers": [
          "Strong analyst consensus with 80.4% recommending a Buy",
          "Recent upgrade from analysts indicating positive outlook",
          "Current price above both short-term and long-term moving averages"
        ],
        "key_risks": [
          "Recent bearish news headlines indicating potential concerns",
          "Market volatility affecting tech stocks",
          "Potential for lower earnings growth in the near term"
        ],
        "price_target_upside": -1.448259040185377
      },
      "risk_flags": {
        "passed_all_checks": true,
        "failed_checks": [],
        "liquidity_ok": true,
        "price_ok": true,
        "no_trading_halts": true,
        "no_pending_ma": true,
        "earnings_clear": true
      },
      "composite_score": 0.5702027577958263,
      "news_summary": "Alphabet Inc. (GOOGL) has received an upgrade to 'Strong Buy' from Raymond James, reflecting positive sentiment around its recent advancements in AI, particularly with the Gemini launch and its applications in shopping. The company's strong performance has positioned it favorably among the 'Magnificent Seven' tech stocks, attracting significant attention from investors. As the market continues to focus on AI developments, GOOGL's initiatives could enhance its growth prospects and investor confidence.",
      "price": 327.98,
      "market_cap": 3957941610132.0,
      "scored_at": "2026-01-23T11:24:41.224826"
    },
    {
      "ticker": "ZTS",
      "sector": "Health Care",
      "theme": null,
      "factor_scores": {
        "value": 0.23333333333333334,
        "quality": 1.0,
        "growth": 0.2,
        "stability": 0.4,
        "revisions": 0.7111111111111111,
        "momentum": -0.0621940187313752
      },
      "sentiment": {
        "overall_sentiment": "bullish",
        "sentiment_score": 0.7,
        "analyst_consensus": "Buy",
        "analyst_score": 0.6,
        "news_sentiment": "bullish",
        "news_score": 0.8,
        "key_drivers": [
          "Strong analyst consensus with 61.1% recommending 'Buy'",
          "Positive news sentiment with multiple bullish headlines",
          "Potential for recovery after a significant share price pullback"
        ],
        "key_risks": [
          "Current RSI indicates a neutral position, suggesting potential stagnation",
          "Market volatility could impact performance",
          "Earnings report uncertainty may affect investor confidence"
        ],
        "price_target_upside": 16.553999678094325
      },
      "risk_flags": {
        "passed_all_checks": true,
        "failed_checks": [],
        "liquidity_ok": true,
        "price_ok": true,
        "no_trading_halts": true,
        "no_pending_ma": true,
        "earnings_clear": true
      },
      "composite_score": 0.5234934065154372,
      "news_summary": "Zoetis Inc. (ZTS) has experienced a significant share price decline of approximately 24% over the past year, closing at $124.40, which has led to discussions about its valuation and potential buying opportunities. Despite a slight recovery in the last month, the stock has shown mixed performance, with analysts noting a fading momentum and a recent downgrade from Piper Sandler. However, Zoetis has a strong history of beating earnings estimates, raising questions about its ability to perform well in the upcoming quarterly report. Investors are closely monitoring these developments as they assess the company's position in the animal health sector.",
      "price": 124.26,
      "market_cap": 54760538772.0,
      "scored_at": "2026-01-23T11:29:35.456552"
    },
    {
      "ticker": "JNJ",
      "sector": "Health Care",
      "theme": null,
      "factor_scores": {
        "value": 0.6,
        "quality": 0.7,
        "growth": 0.2,
        "stability": 0.7,
        "revisions": 0.5615384615384615,
        "momentum": -0.04839003506854328
      },
      "sentiment": {
        "overall_sentiment": "bullish",
        "sentiment_score": 0.6,
        "analyst_consensus": "Hold",
        "analyst_score": 0.2,
        "news_sentiment": "bullish",
        "news_score": 0.6,
        "key_drivers": [
          "Price target raised to $250 from $222 at TD Cowen",
          "J&J's broadening product pipeline can bring 'new era'",
          "Strong technical indicators with RSI14 at 67.6"
        ],
        "key_risks": [
          "Concerns over Social Security benefit cuts impacting consumer spending",
          "Market volatility affecting overall stock performance",
          "Potential regulatory challenges in the pharmaceutical sector"
        ],
        "price_target_upside": 1.7352685316606344
      },
      "risk_flags": {
        "passed_all_checks": true,
        "failed_checks": [],
        "liquidity_ok": true,
        "price_ok": true,
        "no_trading_halts": true,
        "no_pending_ma": true,
        "earnings_clear": true
      },
      "composite_score": 0.5226041375242085,
      "news_summary": "Johnson & Johnson (JNJ) has received a price target increase from TD Cowen, rising to $250 from $222, following strong Q4 results that exceeded revenue expectations at $24.6 billion. Analysts are optimistic about the company's pharmaceutical and medical device segments, anticipating continued momentum through 2026. Additionally, JNJ's stock has gained approximately 5% over the past month and over 13% in the last three months, indicating renewed investor interest amidst its diversified healthcare offerings.",
      "price": 218.41,
      "market_cap": 526214143228.0,
      "scored_at": "2026-01-23T11:26:02.986874"
    },
    {
      "ticker": "AMGN",
      "sector": "Health Care",
      "theme": null,
      "factor_scores": {
        "value": 0.3666666666666667,
        "quality": 0.7,
        "growth": 0.7,
        "stability": 0.7,
        "revisions": 0.4939393939393939,
        "momentum": 0.39352483107596375
      },
      "sentiment": {
        "overall_sentiment": "neutral",
        "sentiment_score": 0.1,
        "analyst_consensus": "Hold",
        "analyst_score": 0.0,
        "news_sentiment": "bullish",
        "news_score": 0.2,
        "key_drivers": [
          "Strong performance relative to the stock market",
          "Positive outlook on MariTide obesity treatment potential"
        ],
        "key_risks": [
          "Ongoing 340B lawsuit could impact stakeholder strategy",
          "Mixed analyst recommendations with a majority holding"
        ],
        "price_target_upside": 4.060773881148787
      },
      "risk_flags": {
        "passed_all_checks": true,
        "failed_checks": [],
        "liquidity_ok": true,
        "price_ok": true,
        "no_trading_halts": true,
        "no_pending_ma": true,
        "earnings_clear": true
      },
      "composite_score": 0.5165747755057818,
      "news_summary": "Amgen (AMGN) has recently attracted attention due to a lawsuit filed by Sagebrush Health Services, alleging unlawful termination of 340B discounted drug sales, which could pose legal and reputational risks for the company. Despite this challenge, Amgen's stock has shown resilience, closing at $347.07 with a 1.01% increase, outperforming broader market gains. Additionally, the company is highlighted as a potential buy in 2026, driven by promising developments in its MariTide obesity and Type 2 diabetes treatment pipeline. The ongoing scrutiny of its stakeholder strategies and market performance will be crucial for investors to monitor.",
      "price": 344.885,
      "market_cap": 185713906218.0,
      "scored_at": "2026-01-23T11:29:23.807012"
    },
    {
      "ticker": "REGN",
      "sector": "Health Care",
      "theme": "Health and Biotech Innovation",
      "factor_scores": {
        "value": 0.7,
        "quality": 0.5,
        "growth": 0.2,
        "stability": 0.7,
        "revisions": 0.676923076923077,
        "momentum": 0.09390051038746332
      },
      "sentiment": {
        "overall_sentiment": "bullish",
        "sentiment_score": 0.6,
        "analyst_consensus": "Buy",
        "analyst_score": 0.61,
        "news_sentiment": "bullish",
        "news_score": 0.75,
        "key_drivers": [
          "Strong analyst consensus with 61.5% recommending 'Buy'",
          "Positive news regarding Regeneron's biologics pipeline and capital return focus",
          "Growth potential in the antibody discovery market driven by AI and technology innovations"
        ],
        "key_risks": [
          "Recent underperformance compared to competitors despite daily gains",
          "Potential negative impact from the competition in the healthcare sector",
          "Concerns raised by the bearish news regarding high school scientists competition"
        ],
        "price_target_upside": 7.7233929047746175
      },
      "risk_flags": {
        "passed_all_checks": true,
        "failed_checks": [],
        "liquidity_ok": true,
        "price_ok": true,
        "no_trading_halts": true,
        "no_pending_ma": true,
        "earnings_clear": true
      },
      "composite_score": 0.5117974602016009,
      "news_summary": "Regeneron Pharmaceuticals (REGN) is gaining investor attention due to its extensive biologics pipeline and disciplined capital allocation strategy, avoiding large acquisitions while focusing on long-term initiatives like the Regeneron Science Talent Search. Despite recent daily gains, REGN's stock has underperformed compared to competitors, indicating potential market challenges. The broader antibody discovery market is expected to grow significantly, which could benefit Regeneron as it continues to innovate in this space. Analysts suggest that the company's strategic focus on its pipeline may enhance its investment appeal moving forward.",
      "price": 749.8,
      "market_cap": 77441082036.0,
      "scored_at": "2026-01-23T11:29:02.613996"
    },
    {
      "ticker": "META",
      "sector": "Communication Services",
      "theme": null,
      "factor_scores": {
        "value": 0.4666666666666667,
        "quality": 1.0,
        "growth": 1.0,
        "stability": -0.2,
        "revisions": 0.6,
        "momentum": 0.5490227663230254
      },
      "sentiment": {
        "overall_sentiment": "bullish",
        "sentiment_score": 0.7,
        "analyst_consensus": "Buy",
        "analyst_score": 0.6,
        "news_sentiment": null,
        "news_score": null,
        "key_drivers": [
          "Upgrade by Morgan Stanley indicates positive outlook",
          "Strong technical indicators with SMA20 and SMA50",
          "RSI14 suggests potential for upward momentum"
        ],
        "key_risks": [
          "Downgrade by Goldman Sachs may create uncertainty",
          "Current price significantly above price target could indicate overvaluation",
          "Lack of recent news may lead to volatility"
        ],
        "price_target_upside": -47.07006335713416
      },
      "risk_flags": {
        "passed_all_checks": true,
        "failed_checks": [],
        "liquidity_ok": true,
        "price_ok": true,
        "no_trading_halts": true,
        "no_pending_ma": true,
        "earnings_clear": true
      },
      "composite_score": 0.49122330633284245,
      "news_summary": null,
      "price": 661.2515,
      "market_cap": 1666740688833.0,
      "scored_at": "2026-01-23T11:24:45.679965"
    },
    {
      "ticker": "LVS",
      "sector": "Consumer Discretionary",
      "theme": "Consumer Sentiment Recovery",
      "factor_scores": {
        "value": 0.36666666666666664,
        "quality": 0.7,
        "growth": 0.2,
        "stability": 0.4,
        "revisions": 0.7842105263157895,
        "momentum": -0.1031182973106748
      },
      "sentiment": {
        "overall_sentiment": "bullish",
        "sentiment_score": 0.6,
        "analyst_consensus": "Buy",
        "analyst_score": 0.68,
        "news_sentiment": "bullish",
        "news_score": 0.4,
        "key_drivers": [
          "Strong analyst consensus with 68.4% recommending a buy",
          "Positive news regarding Las Vegas Sands' leadership in the Asia market",
          "Potential for earnings beat as highlighted by analysts"
        ],
        "key_risks": [
          "Low RSI indicates potential for further price decline",
          "Recent bearish news related to broader market concerns",
          "Neutral sentiment in recent earnings exploration news"
        ],
        "price_target_upside": 15.143929912390494
      },
      "risk_flags": {
        "passed_all_checks": true,
        "failed_checks": [],
        "liquidity_ok": true,
        "price_ok": true,
        "no_trading_halts": true,
        "no_pending_ma": true,
        "earnings_clear": true
      },
      "composite_score": 0.46818902009464625,
      "news_summary": "Las Vegas Sands (LVS) is set to release its fourth-quarter 2025 financial results on January 28, 2026, with analysts projecting a strong performance, including anticipated double-digit growth in earnings per share. The company continues to show resilience in the Asian market, particularly with positive contributions from its properties in Macau and Singapore, despite broader macroeconomic risks. Analysts maintain a hold rating on LVS, citing its healthy margins and credit rating, while also noting the potential impact of its share repurchase program on long-term growth. Overall, LVS is viewed as fairly valued with a fair price target of $60.9, reflecting its solid earnings momentum and strategic expansions.",
      "price": 59.925,
      "market_cap": 40517359133.0,
      "scored_at": "2026-01-23T11:29:54.373246"
    },
    {
      "ticker": "CSCO",
      "sector": "Information Technology",
      "theme": null,
      "factor_scores": {
        "value": 0.3333333333333333,
        "quality": 0.7,
        "growth": 0.2,
        "stability": 0.4,
        "revisions": 0.6416666666666666,
        "momentum": -0.03156146179401956
      },
      "sentiment": {
        "overall_sentiment": "bullish",
        "sentiment_score": 0.7,
        "analyst_consensus": "Buy",
        "analyst_score": 0.6,
        "news_sentiment": "bullish",
        "news_score": 0.8,
        "key_drivers": [
          "Strong analyst consensus with 54.2% recommending 'Buy'",
          "Positive news regarding partnerships and market sentiment",
          "Current price is below the price target, indicating potential for growth"
        ],
        "key_risks": [
          "RSI indicates a neutral position, suggesting potential for volatility",
          "Market conditions may affect overall tech sector performance",
          "Dependence on successful execution of partnerships"
        ],
        "price_target_upside": 10.462319615179046
      },
      "risk_flags": {
        "passed_all_checks": true,
        "failed_checks": [],
        "liquidity_ok": true,
        "price_ok": true,
        "no_trading_halts": true,
        "no_pending_ma": true,
        "earnings_clear": true
      },
      "composite_score": 0.46595739070822123,
      "news_summary": "Cisco Systems, Inc. (CSCO) has announced a multi-year partnership with Georgetown University to modernize its Wi-Fi infrastructure, alongside a new AI infrastructure collaboration with SharonAI and Digital Alpha in the Asia Pacific region. Despite these significant partnerships, Cisco's stock has seen a short-term decline of 6.47% over the past month and a 3.54% decline year-to-date. Analysts remain optimistic, with Bank of America reiterating a Buy rating on the stock, indicating potential for recovery as the company pivots towards AI-driven solutions. Overall, Cisco's strategic moves in AI and infrastructure modernization highlight its commitment to staying competitive in the evolving tech landscape.",
      "price": 74.84,
      "market_cap": 295699917095.0,
      "scored_at": "2026-01-23T11:26:36.072618"
    },
    {
      "ticker": "PFE",
      "sector": "Health Care",
      "theme": null,
      "factor_scores": {
        "value": 0.6,
        "quality": 0.5,
        "growth": 0.2,
        "stability": 0.7,
        "revisions": 0.4703703703703703,
        "momentum": -0.08207802240247168
      },
      "sentiment": {
        "overall_sentiment": "bullish",
        "sentiment_score": 0.6,
        "analyst_consensus": "Hold",
        "analyst_score": 0.2,
        "news_sentiment": "bullish",
        "news_score": 0.8,
        "key_drivers": [
          "Positive earnings expectations for Q1",
          "Strong positioning in oncology drugs",
          "Potential strategic advantages from licensing Novavax's adjuvant"
        ],
        "key_risks": [
          "Market competition in the pharmaceutical sector",
          "Regulatory challenges",
          "Dependence on vaccine sales"
        ],
        "price_target_upside": 9.728992006239038
      },
      "risk_flags": {
        "passed_all_checks": true,
        "failed_checks": [],
        "liquidity_ok": true,
        "price_ok": true,
        "no_trading_halts": true,
        "no_pending_ma": true,
        "earnings_clear": true
      },
      "composite_score": 0.4646982246827747,
      "news_summary": "Pfizer (PFE) is positioned as a potential buy ahead of its Q1 2027 earnings, with analysts noting discounted shares, cost-cutting measures, and promising pipeline catalysts that could support dividends and drive stock upside. Additionally, Pfizer has secured a licensing agreement with Novavax for its Matrix-M adjuvant, allowing the company to enhance its vaccine platform while maintaining control over development and commercialization. Despite these positive developments, concerns remain regarding the overall vaccine market and investor sentiment, as Pfizer has struggled to attract investors despite its low valuation.",
      "price": 25.645,
      "market_cap": 145809970171.0,
      "scored_at": "2026-01-23T11:26:13.938823"
    },
    {
      "ticker": "PG",
      "sector": "Consumer Staples",
      "theme": null,
      "factor_scores": {
        "value": 0.2333333333333333,
        "quality": 0.85,
        "growth": 0.0,
        "stability": 0.7,
        "revisions": 0.6555555555555556,
        "momentum": 0.31401968240798456
      },
      "sentiment": {
        "overall_sentiment": "bullish",
        "sentiment_score": 0.4,
        "analyst_consensus": "Buy",
        "analyst_score": 0.5,
        "news_sentiment": "neutral",
        "news_score": 0.0,
        "key_drivers": [
          "Strong analyst consensus with 55.6% Buy recommendations",
          "Positive price target indicating potential growth",
          "Recent bullish news regarding affordability crisis making stocks buyable"
        ],
        "key_risks": [
          "Bearish news regarding product offerings may impact brand perception",
          "Concerns over Social Security cuts could affect consumer spending",
          "Market volatility reflected in mixed news sentiment"
        ],
        "price_target_upside": 10.321635479789574
      },
      "risk_flags": {
        "passed_all_checks": true,
        "failed_checks": [],
        "liquidity_ok": true,
        "price_ok": true,
        "no_trading_halts": true,
        "no_pending_ma": true,
        "earnings_clear": true
      },
      "composite_score": 0.448022101278687,
      "news_summary": "Procter & Gamble (P&G) is implementing significant changes, including cutting 7,000 jobs globally to fund innovative products aimed at revitalizing growth, such as their new premium 'silky' diapers. The company is also focusing on leveraging data and AI to enhance marketing strategies in response to a fragmented media landscape. Amidst cautious consumer sentiment and geopolitical tensions, P&G's executives have noted that shoppers are being more selective, which could impact sales. The upcoming earnings report will be closely watched as P&G navigates these challenges and opportunities.",
      "price": 150.17,
      "market_cap": 350907277053.0,
      "scored_at": "2026-01-23T11:25:50.743617"
    },
    {
      "ticker": "KO",
      "sector": "Consumer Staples",
      "theme": null,
      "factor_scores": {
        "value": 0.13333333333333333,
        "quality": 0.7,
        "growth": 0.0,
        "stability": 0.7,
        "revisions": 0.9461538461538461,
        "momentum": 0.19509080590238262
      },
      "sentiment": {
        "overall_sentiment": "bullish",
        "sentiment_score": 0.5,
        "analyst_consensus": "Buy",
        "analyst_score": 0.7,
        "news_sentiment": "neutral",
        "news_score": 0.0,
        "key_drivers": [
          "Strong analyst consensus with 84.6% recommending 'Buy'",
          "Positive technical indicators with RSI at 61.9 indicating upward momentum",
          "Price target of $80.00 suggests potential for growth"
        ],
        "key_risks": [
          "Recent bearish news headlines may impact investor sentiment",
          "Disappointing performance compared to peers as noted in news articles",
          "Market volatility could affect stock performance"
        ],
        "price_target_upside": 10.895481009148876
      },
      "risk_flags": {
        "passed_all_checks": true,
        "failed_checks": [],
        "liquidity_ok": true,
        "price_ok": true,
        "no_trading_halts": true,
        "no_pending_ma": true,
        "earnings_clear": true
      },
      "composite_score": 0.4295586586449242,
      "news_summary": "Coca-Cola (KO) continues to be a strong contender in the beverage sector, with comparisons being drawn against competitors like PepsiCo and Monster Beverage, highlighting its diversified portfolio. However, the company faces challenges, including recent layoffs announced by a distributor in Lansing, affecting 62 employees. Despite these setbacks, KO remains a popular choice among dividend investors, often compared favorably to other dividend stocks like Altria. Overall, while KO's stability is appealing, investors should monitor its operational adjustments and competitive positioning in the market.",
      "price": 72.14,
      "market_cap": 310466555848.0,
      "scored_at": "2026-01-23T11:25:46.075882"
    },
    {
      "ticker": "AMAT",
      "sector": "Information Technology",
      "theme": null,
      "factor_scores": {
        "value": 0.3333333333333333,
        "quality": 1.0,
        "growth": 0.0,
        "stability": -0.5,
        "revisions": 0.6666666666666666,
        "momentum": 0.07260457147632855
      },
      "sentiment": {
        "overall_sentiment": "bullish",
        "sentiment_score": 0.75,
        "analyst_consensus": "Buy",
        "analyst_score": 0.75,
        "news_sentiment": "bullish",
        "news_score": 0.6,
        "key_drivers": [
          "Strong analyst buy recommendations with no sells",
          "Positive recent news highlighting growth potential in advanced technologies",
          "Technical indicators showing upward momentum with a high RSI"
        ],
        "key_risks": [
          "Potential market volatility affecting stock performance",
          "Dependence on semiconductor market trends",
          "Possible overvaluation concerns after recent price gains"
        ],
        "price_target_upside": 5.838409200105386
      },
      "risk_flags": {
        "passed_all_checks": true,
        "failed_checks": [],
        "liquidity_ok": true,
        "price_ok": true,
        "no_trading_halts": true,
        "no_pending_ma": true,
        "earnings_clear": true
      },
      "composite_score": 0.4280605351496664,
      "news_summary": "Applied Materials (AMAT) has seen a significant rise in its stock price, gaining approximately 74.6% over the past six months, with recent trading at $326.79 per share. The company's display business reported a robust 68.2% revenue increase in Q4, driven by demand for advanced systems and OLED technology. Analysts are optimistic, with some targeting a price of $381, indicating strong growth potential as the company prepares to report its fiscal first quarter results on February 12, 2026. Overall, AMAT's momentum appears to be building, with a 39% increase over the last three months and a total shareholder return of 68.8% over the past year.",
      "price": 322.605,
      "market_cap": 257000830808.0,
      "scored_at": "2026-01-23T11:28:50.701271"
    },
    {
      "ticker": "GILD",
      "sector": "Health Care",
      "theme": null,
      "factor_scores": {
        "value": -0.06666666666666665,
        "quality": 0.35,
        "growth": 0.2,
        "stability": 0.7,
        "revisions": 0.8037037037037037,
        "momentum": 0.9380669635493973
      },
      "sentiment": {
        "overall_sentiment": "bullish",
        "sentiment_score": 0.8,
        "analyst_consensus": "Buy",
        "analyst_score": 0.7,
        "news_sentiment": "bullish",
        "news_score": 0.8,
        "key_drivers": [
          "Strong analyst consensus with 70.4% Buy recommendations",
          "Positive news coverage highlighting clinical trial advancements",
          "Recent stock performance outpacing competitors"
        ],
        "key_risks": [
          "Potential market volatility affecting stock price",
          "Dependence on successful clinical trial outcomes",
          "General economic conditions impacting healthcare sector"
        ],
        "price_target_upside": 0.17055988134966124
      },
      "risk_flags": {
        "passed_all_checks": true,
        "failed_checks": [],
        "liquidity_ok": true,
        "price_ok": true,
        "no_trading_halts": true,
        "no_pending_ma": true,
        "earnings_clear": true
      },
      "composite_score": 0.41089560496619704,
      "news_summary": "Gilead Sciences (GILD) recently reported a positive trading day, closing at $131.14, up 1.57%, and outperforming competitors. The company received attention following the publication of promising Phase 3 trial results for Trodelvy® in combination with Keytruda® for metastatic triple-negative breast cancer, which may establish a new standard of care. Additionally, Gilead is involved in a Phase II clinical trial with 4D Path to advance predictive biomarkers in bladder cancer. Despite a slight decline in share price recently, analysts suggest Gilead remains undervalued with a target price of $141, indicating potential upside.",
      "price": 134.85,
      "market_cap": 167305647162.0,
      "scored_at": "2026-01-23T11:29:18.297338"
    },
    {
      "ticker": "MCD",
      "sector": "Consumer Discretionary",
      "theme": "Consumer Sentiment Recovery",
      "factor_scores": {
        "value": 0.3333333333333333,
        "quality": 0.85,
        "growth": 0.0,
        "stability": 0.7,
        "revisions": 0.49473684210526314,
        "momentum": -0.011340807465491973
      },
      "sentiment": {
        "overall_sentiment": "neutral",
        "sentiment_score": 0.1,
        "analyst_consensus": "Hold",
        "analyst_score": 0.1,
        "news_sentiment": "bullish",
        "news_score": 0.2,
        "key_drivers": [
          "Positive news on global expansion and menu revamp plans",
          "Bullish sentiment from some analysts regarding growth potential"
        ],
        "key_risks": [
          "Concerns over potential pricing wars in the fast-food industry",
          "Mixed analyst recommendations with a significant hold rating"
        ],
        "price_target_upside": 8.410517607747089
      },
      "risk_flags": {
        "passed_all_checks": true,
        "failed_checks": [],
        "liquidity_ok": true,
        "price_ok": true,
        "no_trading_halts": true,
        "no_pending_ma": true,
        "earnings_clear": true
      },
      "composite_score": 0.3934031528608747,
      "news_summary": "McDonald's is undergoing a significant overhaul, planning to open over 8,000 new restaurants globally by 2027 while introducing popular international menu items in the U.S. in 2026. However, the company faces challenges such as increasing risks of a fast-food pricing war and weak earnings per share trends, leading to a Hold rating from analysts. Recently, MCD shares experienced a decline of 1.49%, closing at $302.84, reflecting broader market concerns. Investors should monitor these developments closely as they could impact McDonald's long-term growth and valuation.",
      "price": 308.245,
      "market_cap": 219964993826.0,
      "scored_at": "2026-01-23T11:28:20.058737"
    },
    {
      "ticker": "NVDA",
      "sector": "Information Technology",
      "theme": "AI Infrastructure Buildout",
      "factor_scores": {
        "value": 0.03333333333333335,
        "quality": 1.0,
        "growth": 1.0,
        "stability": -0.5,
        "revisions": 0.9085106382978723,
        "momentum": 0.03207698476343219
      },
      "sentiment": {
        "overall_sentiment": "bullish",
        "sentiment_score": 0.7,
        "analyst_consensus": "Buy",
        "analyst_score": 0.8,
        "news_sentiment": "bullish",
        "news_score": 0.6,
        "key_drivers": [
          "Strong analyst consensus with 83% Buy recommendations",
          "Positive news regarding AI growth and steady budgets",
          "Recent stock price increase on favorable reports"
        ],
        "key_risks": [
          "Bearish news related to market reactions to specific reports",
          "Potential volatility in the tech sector",
          "Concerns over global economic conditions impacting growth"
        ],
        "price_target_upside": -29.49542747766909
      },
      "risk_flags": {
        "passed_all_checks": true,
        "failed_checks": [],
        "liquidity_ok": true,
        "price_ok": true,
        "no_trading_halts": true,
        "no_pending_ma": true,
        "earnings_clear": true
      },
      "composite_score": 0.3848776949853576,
      "news_summary": "Nvidia (NVDA) continues to be a strong player in the AI computing sector, with analysts recommending it as a top stock to hold for the next five years alongside Broadcom. Recent reports indicate that financial services firms are maintaining their AI budgets, which bodes well for Nvidia's growth prospects. Additionally, Nvidia's stock saw a boost following positive reports related to its H200 product in China, reflecting ongoing investor interest and market confidence in its technology. Overall, the enthusiasm for AI's potential to create jobs and drive economic growth remains high among business leaders, further supporting Nvidia's position in the market.",
      "price": 188.08,
      "market_cap": 4579183727650.0,
      "scored_at": "2026-01-23T11:24:57.494733"
    },
    {
      "ticker": "HON",
      "sector": "Industrials",
      "theme": null,
      "factor_scores": {
        "value": 0.13333333333333333,
        "quality": 0.5,
        "growth": 0.2,
        "stability": 0.4,
        "revisions": 0.6161290322580645,
        "momentum": 0.30545608160481147
      },
      "sentiment": {
        "overall_sentiment": "bullish",
        "sentiment_score": 0.6,
        "analyst_consensus": "Buy",
        "analyst_score": 0.7,
        "news_sentiment": "bullish",
        "news_score": 0.4,
        "key_drivers": [
          "Strong analyst consensus with 54.8% Buy recommendations",
          "Positive news regarding leadership announcements and growth outlook",
          "Technical indicators showing strong momentum (RSI14 at 73.7)"
        ],
        "key_risks": [
          "Bearish news regarding earnings expectations",
          "Potential market volatility affecting stock performance",
          "Single Sell recommendation indicating some analyst caution"
        ],
        "price_target_upside": 6.724385429750587
      },
      "risk_flags": {
        "passed_all_checks": true,
        "failed_checks": [],
        "liquidity_ok": true,
        "price_ok": true,
        "no_trading_halts": true,
        "no_pending_ma": true,
        "earnings_clear": true
      },
      "composite_score": 0.37957368949782255,
      "news_summary": "Honeywell International Inc. (NASDAQ: HON) is preparing for a significant spin-off of its Aerospace division, expected to occur in the second half of 2026, which will operate as an independent publicly traded company. The company recently settled litigation with Flexjet, extending their aircraft engine maintenance agreement through 2035, which may alleviate some financial burdens following a $470 million charge related to the dispute. Despite a modest 2.7% increase in shares over the past year, analysts express mixed expectations for Honeywell's upcoming earnings report, indicating potential challenges in achieving a positive earnings surprise.",
      "price": 222.92,
      "market_cap": 141529056407.0,
      "scored_at": "2026-01-23T11:27:52.355542"
    },
    {
      "ticker": "VZ",
      "sector": "Communication Services",
      "theme": null,
      "factor_scores": {
        "value": 0.8,
        "quality": 0.5,
        "growth": 0.0,
        "stability": 0.7,
        "revisions": 0.43333333333333335,
        "momentum": -0.013761856368563204
      },
      "sentiment": {
        "overall_sentiment": "neutral",
        "sentiment_score": 0.0,
        "analyst_consensus": "Hold",
        "analyst_score": 0.0,
        "news_sentiment": "neutral",
        "news_score": 0.0,
        "key_drivers": [
          "Analyst consensus is predominantly 'Hold' with a significant number of 'Buy' recommendations.",
          "Current price is below the price target, indicating potential for upside.",
          "Technical indicators suggest a stable price range."
        ],
        "key_risks": [
          "Bearish news sentiment from recent articles.",
          "RSI indicates the stock is nearing oversold territory.",
          "Market volatility could impact stock performance."
        ],
        "price_target_upside": 18.03672366687186
      },
      "risk_flags": {
        "passed_all_checks": true,
        "failed_checks": [],
        "liquidity_ok": true,
        "price_ok": true,
        "no_trading_halts": true,
        "no_pending_ma": true,
        "earnings_clear": true
      },
      "composite_score": 0.37870975287133823,
      "news_summary": "Verizon recently announced a billion-dollar acquisition aimed at enhancing its competitive edge in the broadband market, which has been increasingly challenging despite the company reporting a net addition of 61,000 new Fios internet customers in Q3 2025. This move reflects Verizon's strategy to bolster its customer base amid stiff competition. Additionally, analysts are closely monitoring the broader market trends, including the impact of jobless claims and economic indicators, which could influence investor sentiment towards dividend-paying stocks like Verizon. Overall, the company's efforts to attract new customers and adapt to market conditions are critical for its future growth prospects.",
      "price": 39.3098,
      "market_cap": 165746842687.0,
      "scored_at": "2026-01-23T11:26:19.240276"
    },
    {
      "ticker": "ADBE",
      "sector": "Information Technology",
      "theme": null,
      "factor_scores": {
        "value": 0.6,
        "quality": 1.0,
        "growth": 0.5,
        "stability": -0.5,
        "revisions": 0.56875,
        "momentum": -0.05768577285233433
      },
      "sentiment": {
        "overall_sentiment": "bullish",
        "sentiment_score": 0.8,
        "analyst_consensus": "Buy",
        "analyst_score": 0.7,
        "news_sentiment": "bullish",
        "news_score": 0.9,
        "key_drivers": [
          "Strong analyst consensus with 56.2% Buy recommendations",
          "Positive news sentiment with multiple bullish headlines",
          "Recent growth in digital media revenues"
        ],
        "key_risks": [
          "Current RSI indicates potential oversold conditions at 33.3",
          "Price is significantly below moving averages (SMA20 and SMA50)",
          "Market volatility may impact tech stocks"
        ],
        "price_target_upside": -33.87732132808103
      },
      "risk_flags": {
        "passed_all_checks": true,
        "failed_checks": [],
        "liquidity_ok": true,
        "price_ok": true,
        "no_trading_halts": true,
        "no_pending_ma": true,
        "earnings_clear": true
      },
      "composite_score": 0.37522924891179354,
      "news_summary": "Adobe (ADBE) is set to report its first-quarter earnings, with analysts anticipating double-digit growth. The company's digital media revenues have shown resilience, driven by AI-powered tools that contributed to an 11% revenue increase and significant user growth. Despite recent stock performance showing a 33% decline over the past year, Adobe is exploring partnerships in generative AI, which may position it favorably in the evolving tech landscape. However, concerns about the broader software sector's vulnerability to AI disruption remain prevalent among investors.",
      "price": 302.09,
      "market_cap": 126454876115.0,
      "scored_at": "2026-01-23T11:26:52.345835"
    },
    {
      "ticker": "QCOM",
      "sector": "Information Technology",
      "theme": null,
      "factor_scores": {
        "value": 0.3666666666666667,
        "quality": 0.7,
        "growth": 0.5,
        "stability": -0.2,
        "revisions": 0.5324324324324324,
        "momentum": -0.21811553793089186
      },
      "sentiment": {
        "overall_sentiment": "neutral",
        "sentiment_score": 0.1,
        "analyst_consensus": "Hold",
        "analyst_score": 0.1,
        "news_sentiment": "bullish",
        "news_score": 0.3,
        "key_drivers": [
          "Positive market performance relative to the broader market",
          "Bullish news articles highlighting potential growth",
          "Recent dividend announcements from related companies"
        ],
        "key_risks": [
          "Bearish news regarding board exit and its impact on investment narrative",
          "Low RSI indicating potential oversold conditions",
          "Majority of analysts recommending a hold"
        ],
        "price_target_upside": 18.04977274894321
      },
      "risk_flags": {
        "passed_all_checks": true,
        "failed_checks": [],
        "liquidity_ok": true,
        "price_ok": true,
        "no_trading_halts": true,
        "no_pending_ma": true,
        "earnings_clear": true
      },
      "composite_score": 0.3673055235047924,
      "news_summary": "Qualcomm (QCOM) has experienced a notable decline, with its stock price dropping 6.8% over the past week and 12.1% over the last month, leading to discussions about whether now is a good time to buy the dip. The company is set to release its first quarter fiscal 2026 earnings on February 4, 2026, amid concerns about handset demand and competitive pressures. Additionally, Qualcomm's board will see a change with the departure of director Christopher D. Young, while the company has affirmed a quarterly cash dividend of $0.89 per share. Despite a slight daily gain of 1.49%, Qualcomm's performance has lagged behind its competitors recently.",
      "price": 157.315,
      "market_cap": 168484365000.0,
      "scored_at": "2026-01-23T11:27:10.270575"
    },
    {
      "ticker": "V",
      "sector": "Financials",
      "theme": null,
      "factor_scores": {
        "value": 0.03333333333333335,
        "quality": 1.0,
        "growth": 0.5,
        "stability": 0.4,
        "revisions": 0.9235294117647058,
        "momentum": -0.024150905023387955
      },
      "sentiment": {
        "overall_sentiment": "bullish",
        "sentiment_score": 0.6,
        "analyst_consensus": "Buy",
        "analyst_score": 0.7,
        "news_sentiment": "bullish",
        "news_score": 0.6,
        "key_drivers": [
          "Strong analyst consensus with 82.4% recommending Buy",
          "Positive news regarding partnerships with crypto firms",
          "Growing interest in cryptocurrencies among traditional finance firms"
        ],
        "key_risks": [
          "Recent bearish assessment of Visa's valuation",
          "Low RSI indicating potential oversold conditions",
          "Market volatility related to cryptocurrency trends"
        ],
        "price_target_upside": -38.575141415685685
      },
      "risk_flags": {
        "passed_all_checks": true,
        "failed_checks": [],
        "liquidity_ok": true,
        "price_ok": true,
        "no_trading_halts": true,
        "no_pending_ma": true,
        "earnings_clear": true
      },
      "composite_score": 0.3598210119923504,
      "news_summary": "Visa (V) has experienced a recent share price decline of 7.6% over the past month, contributing to a flat total return of 0.1% over the past year, despite a strong 70.73% total shareholder return over the last five years. The company has also enabled Apple Pay support for Chinese Visa cardholders, enhancing its digital payment capabilities. Analysts are reassessing Visa's long-term investment narrative, reflecting changes in the global payments landscape and digital spending trends. Overall, while short-term performance has been weak, the long-term outlook remains positive as Visa adapts to evolving market demands.",
      "price": 327.05,
      "market_cap": 634617250160.0,
      "scored_at": "2026-01-23T11:25:15.014383"
    },
    {
      "ticker": "MA",
      "sector": "Financials",
      "theme": null,
      "factor_scores": {
        "value": 0.03333333333333335,
        "quality": 1.0,
        "growth": 0.5,
        "stability": 0.4,
        "revisions": 0.8222222222222222,
        "momentum": -0.25722534475874564
      },
      "sentiment": {
        "overall_sentiment": "bullish",
        "sentiment_score": 0.7,
        "analyst_consensus": "Buy",
        "analyst_score": 0.8,
        "news_sentiment": "bullish",
        "news_score": 0.6,
        "key_drivers": [
          "Strong analyst consensus with 72.2% recommending 'Buy'",
          "Positive news regarding Mastercard's blockchain and open banking initiatives",
          "Recent deals indicating potential growth in rewards and partnerships"
        ],
        "key_risks": [
          "Current RSI indicates potential oversold conditions",
          "Market volatility affecting overall sentiment",
          "Dependence on successful implementation of new strategies"
        ],
        "price_target_upside": -36.12062079196622
      },
      "risk_flags": {
        "passed_all_checks": true,
        "failed_checks": [],
        "liquidity_ok": true,
        "price_ok": true,
        "no_trading_halts": true,
        "no_pending_ma": true,
        "earnings_clear": true
      },
      "composite_score": 0.353359639667573,
      "news_summary": "Mastercard (NYSE:MA) is actively adapting to regulatory pressures and evolving market demands by investing in blockchain technology and open banking initiatives, while also enhancing its loyalty programs through partnerships like the recent Agoda deal. Analysts have shown optimism, with Compass Point upgrading the stock from Neutral to Buy and raising the price target significantly. As the company prepares for its upcoming earnings report, expectations are high for a positive performance. Additionally, the broader trend of increasing interest in cryptocurrencies among traditional finance firms may influence Mastercard's strategic direction moving forward.",
      "price": 525.78,
      "market_cap": 475311346813.0,
      "scored_at": "2026-01-23T11:25:21.287307"
    },
    {
      "ticker": "SYK",
      "sector": "Health Care",
      "theme": null,
      "factor_scores": {
        "value": -0.16666666666666666,
        "quality": 0.7,
        "growth": 0.5,
        "stability": 0.4,
        "revisions": 0.74,
        "momentum": -0.22138564742015934
      },
      "sentiment": {
        "overall_sentiment": "neutral",
        "sentiment_score": 0.1,
        "analyst_consensus": "Buy",
        "analyst_score": 0.6,
        "news_sentiment": "bearish",
        "news_score": -0.4,
        "key_drivers": [
          "Strong analyst consensus with 64% Buy recommendations",
          "Expected earnings growth ahead of upcoming release"
        ],
        "key_risks": [
          "Recent underperformance compared to competitors",
          "Concerns over valuation in the market"
        ],
        "price_target_upside": 19.222260040844105
      },
      "risk_flags": {
        "passed_all_checks": true,
        "failed_checks": [],
        "liquidity_ok": true,
        "price_ok": true,
        "no_trading_halts": true,
        "no_pending_ma": true,
        "earnings_clear": true
      },
      "composite_score": 0.3424736993291988,
      "news_summary": "Stryker Corporation (SYK) is facing mixed performance, with a slight year-to-date gain of 4.1% but a 4.2% decline over the past year, prompting investors to reassess its valuation amid high P/E multiples. The stock underperformed compared to competitors recently, raising concerns about its earnings potential ahead of the upcoming earnings report. Analysts are cautious about SYK's financial outlook, especially in light of broader trends in the medical device sector, where competition is intensifying. As the market evaluates Stryker's strategic positioning, its recent performance highlights the need for careful consideration by investors.",
      "price": 352.56,
      "market_cap": 134827281339.0,
      "scored_at": "2026-01-23T11:29:29.815664"
    },
    {
      "ticker": "MSFT",
      "sector": "Information Technology",
      "theme": null,
      "factor_scores": {
        "value": 0.13333333333333333,
        "quality": 1.0,
        "growth": 0.5,
        "stability": 0.1,
        "revisions": 0.9809523809523809,
        "momentum": 0.1993788230485113
      },
      "sentiment": {
        "overall_sentiment": "bullish",
        "sentiment_score": 0.4,
        "analyst_consensus": "Buy",
        "analyst_score": 0.8,
        "news_sentiment": "neutral",
        "news_score": 0.0,
        "key_drivers": [
          "Strong analyst consensus with 88.1% recommending 'Buy'",
          "Positive price target indicating significant upside potential",
          "Recent bullish news related to Microsoft's AI initiatives"
        ],
        "key_risks": [
          "Bearish news sentiment from some recent headlines",
          "Current RSI indicates potential for downward momentum",
          "Market volatility affecting tech stocks"
        ],
        "price_target_upside": -32.40407382837746
      },
      "risk_flags": {
        "passed_all_checks": true,
        "failed_checks": [],
        "liquidity_ok": true,
        "price_ok": true,
        "no_trading_halts": true,
        "no_pending_ma": true,
        "earnings_clear": true
      },
      "composite_score": 0.3378389008707908,
      "news_summary": "Microsoft (MSFT) is set to report its Q2 earnings next week, with Wall Street closely monitoring key performance metrics amid a challenging market environment. The upcoming earnings are particularly significant as they coincide with a broader trend of tech stocks facing pressure, with investors rotating towards value names. Additionally, the company's recent AI partnerships, including a notable agreement with Bristol Myers Squibb, highlight its ongoing commitment to innovation in the healthcare sector. Overall, the stakes are high for MSFT as it navigates these market dynamics and prepares for its earnings release.",
      "price": 468.6599,
      "market_cap": 3483627072791.0005,
      "scored_at": "2026-01-23T11:24:29.108558"
    },
    {
      "ticker": "ADP",
      "sector": "Information Technology",
      "theme": null,
      "factor_scores": {
        "value": 0.13333333333333333,
        "quality": 0.85,
        "growth": 0.2,
        "stability": 0.4,
        "revisions": -0.09047619047619046,
        "momentum": -0.04483762490392035
      },
      "sentiment": {
        "overall_sentiment": "neutral",
        "sentiment_score": 0.1,
        "analyst_consensus": "Hold",
        "analyst_score": 0.1,
        "news_sentiment": "bullish",
        "news_score": 0.3,
        "key_drivers": [
          "ADP named one of Fortune's Most Admired Companies for 20th straight year",
          "Bullish news articles highlighting potential for significant returns"
        ],
        "key_risks": [
          "Majority of analysts recommend holding rather than buying",
          "Recent performance shows mixed results with losses on the day"
        ],
        "price_target_upside": 7.067001463480762
      },
      "risk_flags": {
        "passed_all_checks": true,
        "failed_checks": [],
        "liquidity_ok": true,
        "price_ok": true,
        "no_trading_halts": true,
        "no_pending_ma": true,
        "earnings_clear": true
      },
      "composite_score": 0.30750206321319207,
      "news_summary": "ADP is set to report its Q2 earnings for December 2025, with analysts focusing on key performance metrics beyond traditional estimates. The company has been recognized as one of Fortune's 'Most Admired Companies' for the 20th consecutive year, highlighting its strong corporate reputation. However, recent ADP payroll data indicates a slowdown in hiring, with only 8,000 jobs added per week in December, reflecting broader economic concerns amid rising borrowing costs. Despite these challenges, ADP's stock has shown resilience, outperforming competitors even on days of overall market losses.",
      "price": 258.9033,
      "market_cap": 104713180782.0,
      "scored_at": "2026-01-23T11:28:07.478509"
    },
    {
      "ticker": "LMT",
      "sector": "Industrials",
      "theme": null,
      "factor_scores": {
        "value": 0.26666666666666666,
        "quality": 0.2,
        "growth": 0.2,
        "stability": 0.7,
        "revisions": 0.3173913043478261,
        "momentum": 0.18277699908287146
      },
      "sentiment": {
        "overall_sentiment": "bullish",
        "sentiment_score": 0.6,
        "analyst_consensus": "Hold",
        "analyst_score": 0.2,
        "news_sentiment": "bullish",
        "news_score": 0.6,
        "key_drivers": [
          "Strong partnerships in AI solutions enhancing growth potential",
          "Positive outlook on defense and aerospace sector performance",
          "Recent bullish news highlighting explosive growth opportunities"
        ],
        "key_risks": [
          "Analysts predicting a decline in earnings",
          "High valuation concerns amidst growth",
          "Competitive pressures from other aerospace-defense companies"
        ],
        "price_target_upside": -1.2717820189327853
      },
      "risk_flags": {
        "passed_all_checks": true,
        "failed_checks": [],
        "liquidity_ok": true,
        "price_ok": true,
        "no_trading_halts": true,
        "no_pending_ma": true,
        "earnings_clear": true
      },
      "composite_score": 0.3035958793748607,
      "news_summary": "Lockheed Martin (LMT) is facing expectations of a decline in earnings in its upcoming report, as analysts indicate it lacks the necessary factors for a potential earnings beat. Despite this, the stock has shown recent positive momentum, closing at $586.23 with a 30-day return of 21.23%. The defense sector is experiencing increased attention due to rising budgets and significant contracts, highlighted by recent market movements following comments from President Trump. Investors are weighing LMT's valuation against its fundamentals amid a backdrop of strong demand for defense hardware.",
      "price": 590.51,
      "market_cap": 137863437227.0,
      "scored_at": "2026-01-23T11:27:22.919430"
    },
    {
      "ticker": "UNH",
      "sector": "Health Care",
      "theme": null,
      "factor_scores": {
        "value": -0.09999999999999999,
        "quality": 0.2,
        "growth": 0.2,
        "stability": 0.7,
        "revisions": 0.676923076923077,
        "momentum": 0.39581858233026573
      },
      "sentiment": {
        "overall_sentiment": "bullish",
        "sentiment_score": 0.6,
        "analyst_consensus": "Buy",
        "analyst_score": 0.7,
        "news_sentiment": "neutral",
        "news_score": 0.0,
        "key_drivers": [
          "Strong analyst consensus with 61.5% recommending Buy",
          "Positive outlook from Mizuho Securities regarding Medicare Advantage",
          "Technical indicators showing upward momentum (RSI of 62.9)"
        ],
        "key_risks": [
          "Concerns raised by Congress regarding affordability",
          "Neutral news sentiment with mixed opinions",
          "Potential impact of political issues on the insurance sector"
        ],
        "price_target_upside": 9.511236489449068
      },
      "risk_flags": {
        "passed_all_checks": true,
        "failed_checks": [],
        "liquidity_ok": true,
        "price_ok": true,
        "no_trading_halts": true,
        "no_pending_ma": true,
        "earnings_clear": true
      },
      "composite_score": 0.3023649874369724,
      "news_summary": "UnitedHealth Group (UNH) is facing political pressure as it prepares to rebate ACA profits, although the financial impact on its stock is expected to be limited. Mizuho Securities maintains a positive outlook, reiterating a Buy rating with a price target of $430 ahead of the Medicare Advantage 2027 Advance Notice. However, concerns about rising medical costs and a higher medical care ratio may pressure earnings as the company approaches its Q4 earnings report. Investors are advised to wait for more insights on January 27 before making decisions regarding UNH stock.",
      "price": 355.3334,
      "market_cap": 321874716696.0,
      "scored_at": "2026-01-23T11:25:57.108250"
    },
    {
      "ticker": "BIIB",
      "sector": "Health Care",
      "theme": null,
      "factor_scores": {
        "value": 0.7999999999999999,
        "quality": 0.5,
        "growth": -0.5,
        "stability": 0.7,
        "revisions": 0.40303030303030296,
        "momentum": 0.11815071879140293
      },
      "sentiment": {
        "overall_sentiment": "neutral",
        "sentiment_score": 0.1,
        "analyst_consensus": "Hold",
        "analyst_score": 0.1,
        "news_sentiment": "bullish",
        "news_score": 0.2,
        "key_drivers": [
          "Strong trading performance compared to competitors",
          "Positive outlook from analysts on biotech sector",
          "Recent funding for innovative obesity treatment"
        ],
        "key_risks": [
          "Underperformance compared to competitors on certain days",
          "Concerns about future challenges in the pharmaceutical sector",
          "High percentage of Hold recommendations from analysts"
        ],
        "price_target_upside": 5.909888823873607
      },
      "risk_flags": {
        "passed_all_checks": true,
        "failed_checks": [],
        "liquidity_ok": true,
        "price_ok": true,
        "no_trading_halts": true,
        "no_pending_ma": true,
        "earnings_clear": true
      },
      "composite_score": 0.30115292023104806,
      "news_summary": "Biogen Inc. has faced a challenging market environment, with recent reports indicating underperformance compared to competitors and expectations of a significant earnings drop in its upcoming quarterly report. Analysts have expressed concerns about revenue headwinds, particularly due to erosion in its multiple sclerosis franchise and a weak pipeline, leading to a downgrade of the stock to 'sell.' Despite a recent recovery in share price, long-term performance remains concerning, with substantial declines over the past few years. Investors should be cautious as the company navigates these difficulties in 2026.",
      "price": 170.9,
      "market_cap": 25071418285.0,
      "scored_at": "2026-01-23T11:29:12.590095"
    },
    {
      "ticker": "VRTX",
      "sector": "Health Care",
      "theme": "Health and Biotech Innovation",
      "factor_scores": {
        "value": -0.6,
        "quality": 0.19999999999999998,
        "growth": 0.5,
        "stability": 0.7,
        "revisions": 0.6862068965517241,
        "momentum": 0.5017049424344605
      },
      "sentiment": {
        "overall_sentiment": "bullish",
        "sentiment_score": 0.8,
        "analyst_consensus": "Buy",
        "analyst_score": 0.7,
        "news_sentiment": "bullish",
        "news_score": 0.8,
        "key_drivers": [
          "Strong analyst recommendations with 58.6% Buy ratings",
          "Positive news regarding pipeline developments and market opportunities",
          "Recent performance exceeding market returns"
        ],
        "key_risks": [
          "Potential volatility in biotech sector",
          "Dependence on successful pipeline outcomes",
          "Market competition in genetic engineering tools"
        ],
        "price_target_upside": 8.445171497142615
      },
      "risk_flags": {
        "passed_all_checks": true,
        "failed_checks": [],
        "liquidity_ok": true,
        "price_ok": true,
        "no_trading_halts": true,
        "no_pending_ma": true,
        "earnings_clear": true
      },
      "composite_score": 0.29876755883513845,
      "news_summary": "Vertex Pharmaceuticals (VRTX) has recently seen positive momentum, with its stock closing at $467.35, reflecting a 1.35% increase. Analysts have shown bullish sentiment, with Bernstein upgrading the stock to Outperform and naming it a top biotech pick for 2026, citing strong prospects for its cystic fibrosis pipeline and upcoming clinical data. The company is set to announce its fourth quarter and full year 2025 financial results on February 12, 2026, which could further influence investor sentiment.",
      "price": 464.585,
      "market_cap": 119115250595.0,
      "scored_at": "2026-01-23T11:28:55.386593"
    },
    {
      "ticker": "PEP",
      "sector": "Consumer Staples",
      "theme": null,
      "factor_scores": {
        "value": 0.26666666666666666,
        "quality": 0.55,
        "growth": 0.0,
        "stability": 0.7,
        "revisions": 0.4076923076923077,
        "momentum": -0.17568397352800727
      },
      "sentiment": {
        "overall_sentiment": "neutral",
        "sentiment_score": 0.1,
        "analyst_consensus": "Hold",
        "analyst_score": 0.1,
        "news_sentiment": "neutral",
        "news_score": 0.0,
        "key_drivers": [
          "Recent bullish news regarding strategic partnerships and upgrades",
          "Analyst recommendations showing a majority hold with some buy support"
        ],
        "key_risks": [
          "Bearish news impacting stock performance",
          "Recent price decline amidst market gains"
        ],
        "price_target_upside": 12.604104958706468
      },
      "risk_flags": {
        "passed_all_checks": true,
        "failed_checks": [],
        "liquidity_ok": true,
        "price_ok": true,
        "no_trading_halts": true,
        "no_pending_ma": true,
        "earnings_clear": true
      },
      "composite_score": 0.2931603480249179,
      "news_summary": "PepsiCo (PEP) recently received an upgrade from JPMorgan following the company's announcement of a restructuring plan aimed at enhancing shareholder returns and streamlining its product lineup. Despite this positive development, PEP's stock closed at $144.42, reflecting a decline of 1.58% in the latest trading session. Additionally, CEO Ramon Laguarta emphasized the need to reframe the sustainability debate in relation to profitability during a recent World Economic Forum event. Overall, these developments indicate a strategic shift for PepsiCo as it navigates operational challenges and seeks to expand its international presence.",
      "price": 143.485,
      "market_cap": 196192797405.0,
      "scored_at": "2026-01-23T11:25:40.245668"
    },
    {
      "ticker": "NFLX",
      "sector": "Communication Services",
      "theme": null,
      "factor_scores": {
        "value": 0.3666666666666667,
        "quality": 1.0,
        "growth": 0.7,
        "stability": -0.5,
        "revisions": 0.6945945945945945,
        "momentum": -0.19131175468483816
      },
      "sentiment": {
        "overall_sentiment": "neutral",
        "sentiment_score": 0.1,
        "analyst_consensus": "Buy",
        "analyst_score": 0.5,
        "news_sentiment": "neutral",
        "news_score": 0.0,
        "key_drivers": [
          "Strong analyst consensus with 62.2% recommending a buy",
          "Potential for hidden subscriber growth",
          "Co-CEO's positive outlook on shareholder backing"
        ],
        "key_risks": [
          "Recent price target reductions by analysts",
          "Bearish news sentiment from multiple sources",
          "Low RSI indicating potential oversold conditions"
        ],
        "price_target_upside": -30.621596926978444
      },
      "risk_flags": {
        "passed_all_checks": true,
        "failed_checks": [],
        "liquidity_ok": true,
        "price_ok": true,
        "no_trading_halts": true,
        "no_pending_ma": true,
        "earnings_clear": true
      },
      "composite_score": 0.27450210005576275,
      "news_summary": "Netflix (NFLX) has faced a price target reduction from Argus, lowering it to $110 amid concerns over its aggressive bid for Warner Bros. Discovery (WBD) and potential regulatory challenges. Despite surpassing 325 million subscribers, investor sentiment remains cautious due to high spending plans and competition, particularly from Paramount's rival bid. Co-CEO Greg Peters expressed confidence in securing shareholder backing for the WBD acquisition, while analysts continue to adjust their outlooks on the stock following its recent performance.",
      "price": 85.8048,
      "market_cap": 392085033600.0,
      "scored_at": "2026-01-23T11:25:34.205691"
    },
    {
      "ticker": "NEE",
      "sector": "Utilities",
      "theme": "Energy Transition and Sustainability",
      "factor_scores": {
        "value": 0.36666666666666664,
        "quality": 0.25,
        "growth": -0.5,
        "stability": 0.7,
        "revisions": 0.6833333333333333,
        "momentum": 0.21646996796041743
      },
      "sentiment": {
        "overall_sentiment": "bullish",
        "sentiment_score": 0.6,
        "analyst_consensus": "Buy",
        "analyst_score": 0.7,
        "news_sentiment": "bullish",
        "news_score": 0.4,
        "key_drivers": [
          "Strong analyst consensus with 62.5% recommending 'Buy'",
          "Positive news coverage highlighting growth potential",
          "Technical indicators showing a healthy RSI of 62.3"
        ],
        "key_risks": [
          "Bearish news headline suggesting potential overvaluation",
          "Only one 'Sell' recommendation indicating some skepticism",
          "Market volatility affecting utility stocks"
        ],
        "price_target_upside": 7.973421926910297
      },
      "risk_flags": {
        "passed_all_checks": true,
        "failed_checks": [],
        "liquidity_ok": true,
        "price_ok": true,
        "no_trading_halts": true,
        "no_pending_ma": true,
        "earnings_clear": true
      },
      "composite_score": 0.2618953952997024,
      "news_summary": "NextEra Energy (NEE) is gaining attention as a strong player in the clean energy sector, with a focus on AI and renewable energy growth, although its current valuation appears high. The company is expanding its nuclear and solar initiatives while trading below previous highs ahead of its earnings report. Recent performance metrics show NEE's stock has delivered solid returns over various time frames, and it is positioned favorably against competitors like Southern Company due to its cleaner energy focus and growth forecasts. However, concerns about overbuilding transmission infrastructure could impact future projects.",
      "price": 84.28,
      "market_cap": 175522368258.0,
      "scored_at": "2026-01-23T11:30:44.285566"
    },
    {
      "ticker": "JPM",
      "sector": "Financials",
      "theme": null,
      "factor_scores": {
        "value": 0.16666666666666666,
        "quality": 0.25,
        "growth": 0.0,
        "stability": 0.1,
        "revisions": 0.6599999999999999,
        "momentum": -0.3339098295295355
      },
      "sentiment": {
        "overall_sentiment": "bullish",
        "sentiment_score": 0.7,
        "analyst_consensus": "Buy",
        "analyst_score": 0.6,
        "news_sentiment": "bullish",
        "news_score": 0.6,
        "key_drivers": [
          "Acquisition of pensions technology platform WealthOS enhances service offerings.",
          "Positive news regarding JPMorgan's competitive position in self-directed investing.",
          "Strong analyst support with a majority recommending 'Buy'."
        ],
        "key_risks": [
          "Current RSI indicates potential oversold conditions.",
          "Market volatility could impact short-term performance.",
          "Economic factors affecting banking sector profitability."
        ],
        "price_target_upside": 9.87542087542087
      },
      "risk_flags": {
        "passed_all_checks": true,
        "failed_checks": [],
        "liquidity_ok": true,
        "price_ok": true,
        "no_trading_halts": true,
        "no_pending_ma": true,
        "earnings_clear": true
      },
      "composite_score": 0.24775032557795862,
      "news_summary": "JPMorgan has made headlines with its acquisition of the British wealth management software platform WealthOS, enhancing its Nutmeg personal investing division. The bank also recently initiated coverage on Helios Technologies with an Overweight rating, indicating confidence in its growth strategy. Additionally, JPMorgan continues to excel in the online brokerage space, recognized for its trade execution and customer service. However, the bank faces legal challenges, including a $5 billion lawsuit from former President Trump alleging politically motivated account closures.",
      "price": 297.0,
      "market_cap": 808511880528.0,
      "scored_at": "2026-01-23T11:25:08.859595"
    },
    {
      "ticker": "MMM",
      "sector": "Industrials",
      "theme": null,
      "factor_scores": {
        "value": 0.13333333333333333,
        "quality": 0.55,
        "growth": 0.0,
        "stability": 0.1,
        "revisions": 0.5444444444444444,
        "momentum": -0.40466588739528464
      },
      "sentiment": {
        "overall_sentiment": "bullish",
        "sentiment_score": 0.3,
        "analyst_consensus": "Buy",
        "analyst_score": 0.5,
        "news_sentiment": "neutral",
        "news_score": 0.0,
        "key_drivers": [
          "Majority of analysts recommend a 'Buy' rating.",
          "Current price is below the price target, indicating potential for upside.",
          "Technical indicators show stability with SMA20 and SMA50 close to current price."
        ],
        "key_risks": [
          "Bearish news regarding consumer sentiment and global tensions.",
          "Only one analyst rated it as 'Sell', indicating some skepticism.",
          "RSI indicates the stock is neither overbought nor oversold, suggesting caution."
        ],
        "price_target_upside": 4.102690087212878
      },
      "risk_flags": {
        "passed_all_checks": true,
        "failed_checks": [],
        "liquidity_ok": true,
        "price_ok": true,
        "no_trading_halts": true,
        "no_pending_ma": true,
        "earnings_clear": true
      },
      "composite_score": 0.24131220642033038,
      "news_summary": "3M Company (MMM) shares rose 3.7% following the announcement of a framework for a future deal with Greenland, indicating positive market sentiment. Despite this uptick, analysts suggest that the stock is currently at fair value with moderate sales growth and ongoing litigation liabilities, leading to a 'hold' recommendation. Additionally, the company faces potential tariff risks related to its operations in Greenland, which could impact future guidance. Overall, while there are positive developments, caution remains due to external economic factors and internal challenges.",
      "price": 162.82,
      "market_cap": 86494064595.0,
      "scored_at": "2026-01-23T11:27:46.090420"
    },
    {
      "ticker": "FCX",
      "sector": "Materials",
      "theme": "Inflation Hedge Investments",
      "factor_scores": {
        "value": 0.6666666666666666,
        "quality": 0.5,
        "growth": 0.0,
        "stability": -0.2,
        "revisions": 0.8272727272727273,
        "momentum": 0.07435512563931464
      },
      "sentiment": {
        "overall_sentiment": "bullish",
        "sentiment_score": 0.8,
        "analyst_consensus": "Buy",
        "analyst_score": 0.7,
        "news_sentiment": "bullish",
        "news_score": 0.8,
        "key_drivers": [
          "Strong analyst consensus with 72.7% Buy recommendations",
          "Positive news regarding expansion of high-grade deposits",
          "Resilient performance highlighted in recent earnings call"
        ],
        "key_risks": [
          "Potential market volatility affecting commodity prices",
          "Economic challenges that could impact demand",
          "High RSI indicating possible overbought conditions"
        ],
        "price_target_upside": -9.64651470102411
      },
      "risk_flags": {
        "passed_all_checks": true,
        "failed_checks": [],
        "liquidity_ok": true,
        "price_ok": true,
        "no_trading_halts": true,
        "no_pending_ma": true,
        "earnings_clear": true
      },
      "composite_score": 0.23985530316389486,
      "news_summary": "Freeport-McMoRan Inc (FCX) reported a strong Q4 2025 performance, achieving a 48% profit increase driven by rising copper and gold prices, despite a slight 1.5% drop in revenue year-over-year. The company successfully navigated challenges at its Grasberg complex, with operations recovering after a September incident. Additionally, FCX's strategic growth initiatives and the expansion of the high-grade Aurora copper-gold-silver deposit in collaboration with Amarc Resources indicate potential for future growth. Analysts remain optimistic about FCX's resilience and operational improvements moving forward.",
      "price": 60.54,
      "market_cap": 86931242156.0,
      "scored_at": "2026-01-23T11:30:25.746628"
    },
    {
      "ticker": "WMT",
      "sector": "Consumer Staples",
      "theme": null,
      "factor_scores": {
        "value": -0.39999999999999997,
        "quality": 0.05000000000000002,
        "growth": 0.2,
        "stability": 0.7,
        "revisions": 1.0,
        "momentum": -0.08948545861297547
      },
      "sentiment": {
        "overall_sentiment": "bullish",
        "sentiment_score": 0.7,
        "analyst_consensus": "Buy",
        "analyst_score": 0.8,
        "news_sentiment": "bullish",
        "news_score": 0.6,
        "key_drivers": [
          "Strong analyst consensus with 93.9% recommending buy",
          "Positive news regarding Walmart's strategic initiatives and leadership",
          "Technical indicators showing upward momentum (RSI14 at 58.8)"
        ],
        "key_risks": [
          "Concerns over executive compensation amidst C-suite changes",
          "Potential market volatility affecting retail performance",
          "Economic factors impacting consumer spending"
        ],
        "price_target_upside": 6.7858353100643765
      },
      "risk_flags": {
        "passed_all_checks": true,
        "failed_checks": [],
        "liquidity_ok": true,
        "price_ok": true,
        "no_trading_halts": true,
        "no_pending_ma": true,
        "earnings_clear": true
      },
      "composite_score": 0.2314530733993821,
      "news_summary": "Walmart (WMT) has recently made headlines with its entry into the Nasdaq-100 Index and the launch of a Premium Musical Instrument Shop, signaling a strategic shift towards higher-value specialty categories. The company is also under new leadership with CEO John Furner, who is expected to focus on key priorities for maintaining success. Despite these developments, WMT's stock saw a slight decline of 1.25% in the latest trading session, closing at $117.87. Analysts continue to highlight Walmart's strong omnichannel execution and positive fiscal outlook, reinforcing its position as a leading retail player.",
      "price": 118.04,
      "market_cap": 941115370875.0,
      "scored_at": "2026-01-23T11:28:33.661721"
    },
    {
      "ticker": "DHR",
      "sector": "Health Care",
      "theme": null,
      "factor_scores": {
        "value": -0.06666666666666665,
        "quality": 0.5,
        "growth": -0.5,
        "stability": 0.4,
        "revisions": 0.8894736842105263,
        "momentum": -0.14485805994414067
      },
      "sentiment": {
        "overall_sentiment": "bullish",
        "sentiment_score": 0.7,
        "analyst_consensus": "Buy",
        "analyst_score": 0.8,
        "news_sentiment": "bullish",
        "news_score": 0.6,
        "key_drivers": [
          "Strong analyst consensus with 78.9% Buy recommendations",
          "Positive news sentiment with multiple bullish headlines",
          "Recent stock performance outpacing competitors"
        ],
        "key_risks": [
          "Potential market volatility affecting stock performance",
          "Dependence on upcoming earnings report outcomes",
          "General economic conditions impacting the diagnostics sector"
        ],
        "price_target_upside": 6.283379790199368
      },
      "risk_flags": {
        "passed_all_checks": true,
        "failed_checks": [],
        "liquidity_ok": true,
        "price_ok": true,
        "no_trading_halts": true,
        "no_pending_ma": true,
        "earnings_clear": true
      },
      "composite_score": 0.22702012580048786,
      "news_summary": "Danaher (DHR) is set to report its Q4 earnings on January 28, with expectations of a 3.9% revenue increase driven by strengths in bioprocessing and diagnostics. The stock has recently outperformed competitors, reflecting a positive trend with a 7.44% return over the past three months, although it experienced a slight decline of 0.7% in the short term. Analysts suggest that DHR may beat earnings estimates, prompting renewed interest among investors, especially following a recent price target reset that indicates a reassessment of the company's prospects.",
      "price": 234.985,
      "market_cap": 168261378176.0,
      "scored_at": "2026-01-23T11:29:41.640932"
    },
    {
      "ticker": "GOLD",
      "sector": "Materials",
      "theme": "Geopolitical Risk and Safe Havens",
      "factor_scores": {
        "value": -0.06666666666666665,
        "quality": -0.4,
        "growth": 0.5,
        "stability": 0.7,
        "revisions": 0.85,
        "momentum": 0.6537374241290421
      },
      "sentiment": {
        "overall_sentiment": "bullish",
        "sentiment_score": 0.8,
        "analyst_consensus": "Buy",
        "analyst_score": 0.75,
        "news_sentiment": "bullish",
        "news_score": 0.8,
        "key_drivers": [
          "Strong analyst consensus with 75% Buy recommendations",
          "Positive news flow highlighting exploration and production updates",
          "Technical indicators showing strong momentum (RSI at 73.6)"
        ],
        "key_risks": [
          "Market volatility affecting gold prices",
          "Potential operational risks in exploration projects",
          "High RSI indicating possible overbought conditions"
        ],
        "price_target_upside": -2.8564820168844673
      },
      "risk_flags": {
        "passed_all_checks": true,
        "failed_checks": [],
        "liquidity_ok": true,
        "price_ok": true,
        "no_trading_halts": true,
        "no_pending_ma": true,
        "earnings_clear": true
      },
      "composite_score": 0.22592752146231374,
      "news_summary": "Gold.com (GOLD) recently closed at $42.67, reflecting a 1.26% increase, and has shown a notable surge of 9.8% in a previous session, although analysts suggest that earnings estimate revisions do not indicate sustained strength. A2Gold Corp. has expanded its Eastside drill program to 30,000 meters, marking the largest in its history, while Rua Gold is ramping up exploration activities at its Auld Creek project in New Zealand, with promising assay results. Additionally, Gold.com is set to hold its fiscal second quarter earnings call on February 5, 2026, which may provide further insights into its performance.",
      "price": 43.235,
      "market_cap": 1065500029.0,
      "scored_at": "2026-01-23T11:30:07.310599"
    },
    {
      "ticker": "AAPL",
      "sector": "Information Technology",
      "theme": null,
      "factor_scores": {
        "value": 0.03333333333333335,
        "quality": 1.0,
        "growth": 0.2,
        "stability": 0.1,
        "revisions": 0.5871794871794872,
        "momentum": -0.32773711320243126
      },
      "sentiment": {
        "overall_sentiment": "bullish",
        "sentiment_score": 0.5,
        "analyst_consensus": "Buy",
        "analyst_score": 0.5,
        "news_sentiment": "neutral",
        "news_score": 0.0,
        "key_drivers": [
          "Majority of analysts recommend 'Buy'",
          "Positive price target indicating potential growth",
          "Strong brand presence and market position"
        ],
        "key_risks": [
          "Low RSI indicating potential oversold conditions",
          "Recent bearish news affecting overall market sentiment",
          "Regulatory challenges in Europe"
        ],
        "price_target_upside": -39.69431786103158
      },
      "risk_flags": {
        "passed_all_checks": true,
        "failed_checks": [],
        "liquidity_ok": true,
        "price_ok": true,
        "no_trading_halts": true,
        "no_pending_ma": true,
        "earnings_clear": true
      },
      "composite_score": 0.21333119973761314,
      "news_summary": "Apple (AAPL) is set to report quarterly earnings next week, alongside other major tech companies, amid a challenging market environment characterized by geopolitical risks and a shift in investor focus from tech to value stocks. The company is also facing regulatory challenges, accusing the European Commission of delaying new app policies that could impact its operations. Additionally, rising memory-chip prices, which have affected Intel, may pose a risk to Apple's supply chain and profitability. As investor interest in AAPL remains high, the upcoming earnings report will be crucial for determining its market trajectory.",
      "price": 247.97,
      "market_cap": 3664092198296.0,
      "scored_at": "2026-01-23T11:24:22.756676"
    },
    {
      "ticker": "IBM",
      "sector": "Information Technology",
      "theme": null,
      "factor_scores": {
        "value": 0.033333333333333326,
        "quality": 0.35,
        "growth": 0.0,
        "stability": 0.7,
        "revisions": 0.29047619047619044,
        "momentum": -0.14348044973988913
      },
      "sentiment": {
        "overall_sentiment": "neutral",
        "sentiment_score": 0.1,
        "analyst_consensus": "Hold",
        "analyst_score": 0.1,
        "news_sentiment": "bullish",
        "news_score": 0.3,
        "key_drivers": [
          "Positive outlook on AI job market",
          "Growth potential in global asset tracking software market",
          "Analyst interest in IBM's Q4 potential"
        ],
        "key_risks": [
          "Majority of analysts recommend holding",
          "RSI indicates potential for downward momentum",
          "Current price below moving averages"
        ],
        "price_target_upside": 6.277720914363691
      },
      "risk_flags": {
        "passed_all_checks": true,
        "failed_checks": [],
        "liquidity_ok": true,
        "price_ok": true,
        "no_trading_halts": true,
        "no_pending_ma": true,
        "earnings_clear": true
      },
      "composite_score": 0.19146691735932497,
      "news_summary": "IBM is expected to report strong Q4 earnings, driven by robust growth in its consulting segment and increased demand for AI-driven tools, with free cash flow guidance raised to $14 billion. The global asset tracking software market, in which IBM is a key player, is projected to grow significantly, indicating a favorable environment for the company's technology solutions. Additionally, industry analysts view IBM as a reliable investment in the AI sector amidst market volatility, further enhancing its attractiveness to investors.",
      "price": 293.1,
      "market_cap": 273970888879.0,
      "scored_at": "2026-01-23T11:27:04.468864"
    },
    {
      "ticker": "COST",
      "sector": "Consumer Staples",
      "theme": null,
      "factor_scores": {
        "value": -0.5,
        "quality": 0.19999999999999998,
        "growth": 0.2,
        "stability": 0.1,
        "revisions": 0.5666666666666667,
        "momentum": 0.21489678599425097
      },
      "sentiment": {
        "overall_sentiment": "bullish",
        "sentiment_score": 0.8,
        "analyst_consensus": "Buy",
        "analyst_score": 0.7,
        "news_sentiment": "bullish",
        "news_score": 0.8,
        "key_drivers": [
          "Strong analyst consensus with 50% Buy recommendations",
          "Positive news regarding new benefits and strong membership fee engine",
          "High RSI indicating strong momentum"
        ],
        "key_risks": [
          "Potential market volatility affecting retail sector",
          "Single Sell recommendation may indicate some caution",
          "High RSI could suggest overbought conditions"
        ],
        "price_target_upside": 4.428970920074766
      },
      "risk_flags": {
        "passed_all_checks": true,
        "failed_checks": [],
        "liquidity_ok": true,
        "price_ok": true,
        "no_trading_halts": true,
        "no_pending_ma": true,
        "earnings_clear": true
      },
      "composite_score": 0.17848714853940878,
      "news_summary": "Costco Wholesale Corporation has declared a quarterly cash dividend of $1.30 per share, reflecting its strong membership fee engine, which generates $5.3 billion annually with high renewal rates of around 90%. The company is also introducing new member benefits in 2026, enhancing its appeal to over 81 million members. Additionally, Costco is expected to benefit from increased consumer spending as winter storms prompt pantry-loading behaviors. Overall, Costco's stock has outperformed the market since January 2020, indicating strong investor confidence.",
      "price": 981.605,
      "market_cap": 435704433185.0,
      "scored_at": "2026-01-23T11:28:26.221823"
    },
    {
      "ticker": "TXN",
      "sector": "Information Technology",
      "theme": null,
      "factor_scores": {
        "value": -0.19999999999999998,
        "quality": 0.85,
        "growth": -0.5,
        "stability": 0.4,
        "revisions": 0.23157894736842108,
        "momentum": 0.1674950648618159
      },
      "sentiment": {
        "overall_sentiment": "bullish",
        "sentiment_score": 0.7,
        "analyst_consensus": "Hold",
        "analyst_score": 0.2,
        "news_sentiment": "bullish",
        "news_score": 0.6,
        "key_drivers": [
          "Positive earnings expectations for Q4",
          "Analyst upgrades indicating strong market position",
          "Bullish news sentiment from multiple sources"
        ],
        "key_risks": [
          "High percentage of Hold recommendations",
          "Potential market volatility affecting stock performance",
          "Economic factors impacting semiconductor demand"
        ],
        "price_target_upside": -3.5077720207253935
      },
      "risk_flags": {
        "passed_all_checks": true,
        "failed_checks": [],
        "liquidity_ok": true,
        "price_ok": true,
        "no_trading_halts": true,
        "no_pending_ma": true,
        "earnings_clear": true
      },
      "composite_score": 0.17035924530040472,
      "news_summary": "Texas Instruments (TXN) is expected to report better-than-anticipated Q4 earnings, driven by recovering demand in industrial, automotive, and data center sectors, despite ongoing cost pressures. Recent analyst upgrades highlight a broad industrial restocking cycle, which could positively impact TXN's revenue and margins. However, the stock has shown underperformance compared to competitors, raising investor concerns about its recent price gains amidst these developments. Analysts are closely monitoring how these trends will influence TXN's upcoming earnings call and overall market positioning.",
      "price": 193.0,
      "market_cap": 175364242860.0,
      "scored_at": "2026-01-23T11:27:16.592454"
    },
    {
      "ticker": "DE",
      "sector": "Industrials",
      "theme": "Regulatory Changes and Trade Policies",
      "factor_scores": {
        "value": 0.13333333333333333,
        "quality": 0.35,
        "growth": -0.5,
        "stability": 0.1,
        "revisions": 0.6555555555555556,
        "momentum": -0.02928575126850901
      },
      "sentiment": {
        "overall_sentiment": "bullish",
        "sentiment_score": 0.6,
        "analyst_consensus": "Buy",
        "analyst_score": 0.7,
        "news_sentiment": "bullish",
        "news_score": 0.6,
        "key_drivers": [
          "Strong analyst buy recommendations with no sell ratings",
          "Positive news regarding outperformance against competitors",
          "Recent bullish sentiment in AgTech and food innovation sectors"
        ],
        "key_risks": [
          "Recent stock drop despite overall market gains",
          "One bearish news headline indicating potential concerns",
          "Market volatility affecting stock performance"
        ],
        "price_target_upside": 3.1660983925962007
      },
      "risk_flags": {
        "passed_all_checks": true,
        "failed_checks": [],
        "liquidity_ok": true,
        "price_ok": true,
        "no_trading_halts": true,
        "no_pending_ma": true,
        "earnings_clear": true
      },
      "composite_score": 0.16976946157980644,
      "news_summary": "Deere (DE) stock closed at $522.38, reflecting a slight decline of 1.35% despite outperforming competitors on strong trading days. Over the past month, the stock has shown a positive trend with a 9.31% return, and an 11.87% return over three months, indicating strong investor interest. Analysts are assessing its valuation in light of recent performance, as the company continues to attract attention in the capital goods sector. Overall, Deere's five-year total shareholder return of 84.13% highlights its momentum in the market.",
      "price": 513.25,
      "market_cap": 139128730500.0,
      "scored_at": "2026-01-23T11:27:39.931412"
    },
    {
      "ticker": "ISRG",
      "sector": "Health Care",
      "theme": null,
      "factor_scores": {
        "value": -0.26666666666666666,
        "quality": 0.7,
        "growth": 1.0,
        "stability": -0.5,
        "revisions": 0.5666666666666667,
        "momentum": -0.20173704757330602
      },
      "sentiment": {
        "overall_sentiment": "bullish",
        "sentiment_score": 0.3,
        "analyst_consensus": "Buy",
        "analyst_score": 0.5,
        "news_sentiment": "neutral",
        "news_score": 0.0,
        "key_drivers": [
          "Strong analyst consensus with 50% Buy recommendations",
          "Positive news regarding the global impact of da Vinci surgery",
          "Stock rise following earnings report"
        ],
        "key_risks": [
          "Low RSI indicating potential oversold conditions",
          "Bearish sentiment in broader market news",
          "Only one Sell recommendation indicating limited downside support"
        ],
        "price_target_upside": -39.36334740737226
      },
      "risk_flags": {
        "passed_all_checks": true,
        "failed_checks": [],
        "liquidity_ok": true,
        "price_ok": true,
        "no_trading_halts": true,
        "no_pending_ma": true,
        "earnings_clear": true
      },
      "composite_score": 0.15547283900444575,
      "news_summary": "Intuitive Surgical (ISRG) reported strong Q4 2025 earnings, with revenue of $2.87 billion and a 21% increase in annual revenue, surpassing Wall Street expectations. The company celebrated a milestone of over 20 million patients treated with its da Vinci surgical systems, highlighting its leadership in robotic-assisted surgery. However, a cautious outlook for 2026 regarding procedure growth amid rising competition has raised concerns among investors about future performance. Overall, the stock has seen positive movement following these results, reflecting investor confidence despite potential market challenges.",
      "price": 526.975,
      "market_cap": 188908149899.0,
      "scored_at": "2026-01-23T11:29:08.025376"
    },
    {
      "ticker": "ABT",
      "sector": "Health Care",
      "theme": "Health and Biotech Innovation",
      "factor_scores": {
        "value": 0.2,
        "quality": 0.35,
        "growth": 0.2,
        "stability": 0.7,
        "revisions": 0.66,
        "momentum": -1.0
      },
      "sentiment": {
        "overall_sentiment": "bullish",
        "sentiment_score": 0.5,
        "analyst_consensus": "Buy",
        "analyst_score": 0.5,
        "news_sentiment": "bullish",
        "news_score": 0.5,
        "key_drivers": [
          "Abbott expects to return to ‘positive growth’ in nutrition in 2H26",
          "The Global Market for Blood Ketone Meters 2026-2031 indicates growth potential"
        ],
        "key_risks": [
          "Recent bearish news affecting overall market sentiment",
          "High RSI indicating potential overbought conditions"
        ],
        "price_target_upside": -35.176536521576686
      },
      "risk_flags": {
        "passed_all_checks": true,
        "failed_checks": [],
        "liquidity_ok": true,
        "price_ok": true,
        "no_trading_halts": true,
        "no_pending_ma": true,
        "earnings_clear": true
      },
      "composite_score": 0.12238095238095238,
      "news_summary": "Abbott Laboratories (ABT) reported a 4.4% year-on-year increase in Q4 sales to $11.46 billion, but missed revenue expectations, primarily due to an 8.9% decline in Worldwide Nutrition sales. The company anticipates returning to positive growth in its nutrition segment by the second half of 2026, supported by strategic pricing actions and new product launches. Despite the recent sales miss, analysts suggest that Abbott remains a solid investment opportunity, particularly for dividend-focused investors.",
      "price": 107.06,
      "market_cap": 186333529192.0,
      "scored_at": "2026-01-23T11:31:18.053212"
    },
    {
      "ticker": "T",
      "sector": "Communication Services",
      "theme": null,
      "factor_scores": {
        "value": 0.7999999999999999,
        "quality": 0.35,
        "growth": -0.5,
        "stability": 0.7,
        "revisions": 0.5583333333333333,
        "momentum": -0.10359601067565728
      },
      "sentiment": {
        "overall_sentiment": "bullish",
        "sentiment_score": 0.4,
        "analyst_consensus": "Buy",
        "analyst_score": 0.5,
        "news_sentiment": "bullish",
        "news_score": 0.2,
        "key_drivers": [
          "Strong analyst consensus with 50% Buy recommendations",
          "Positive news regarding industry growth opportunities",
          "Potential for dividend stability amidst market fluctuations"
        ],
        "key_risks": [
          "Low RSI indicating potential for further price decline",
          "Concerns about preferred shares moving to junk status",
          "Market volatility impacting overall stock performance"
        ],
        "price_target_upside": -38.04649178929409
      },
      "risk_flags": {
        "passed_all_checks": true,
        "failed_checks": [],
        "liquidity_ok": true,
        "price_ok": true,
        "no_trading_halts": true,
        "no_pending_ma": true,
        "earnings_clear": true
      },
      "composite_score": 0.12205098361861946,
      "news_summary": "AT&T (T) is preparing for its Q4 earnings report, with analysts focusing on key performance metrics beyond traditional revenue and EPS estimates. The company is positioned to benefit from the growing Fiber to the Premises market, driven by increasing demand for high-speed internet and government funding for infrastructure upgrades. However, concerns remain regarding its preferred shares, which face potential downgrades and competition from higher-rated alternatives. Institutional investors hold a significant stake in AT&T, indicating their influence on the company's strategic direction amidst challenges in the telecommunications sector.",
      "price": 23.445,
      "market_cap": 166212143410.0,
      "scored_at": "2026-01-23T11:26:29.369724"
    },
    {
      "ticker": "CRWD",
      "sector": "Information Technology",
      "theme": "Small-Cap Growth Surge",
      "factor_scores": {
        "value": 0.2,
        "quality": -0.4,
        "growth": 1.0,
        "stability": 0.1,
        "revisions": 0.6625,
        "momentum": 0.035256410256410464
      },
      "sentiment": {
        "overall_sentiment": "bullish",
        "sentiment_score": 0.7,
        "analyst_consensus": "Buy",
        "analyst_score": 0.6,
        "news_sentiment": "bullish",
        "news_score": 0.6,
        "key_drivers": [
          "Strong analyst support with 58.3% Buy recommendations",
          "Positive news regarding ISO 42001 certification for AI-powered cybersecurity",
          "Upcoming quarterly earnings preview generating interest"
        ],
        "key_risks": [
          "Current RSI indicates potential for oversold conditions",
          "Price is below both SMA20 and SMA50, suggesting short-term weakness",
          "Only 2.1% of analysts recommend selling, indicating limited downside support"
        ],
        "price_target_upside": -39.42939064962353
      },
      "risk_flags": {
        "passed_all_checks": true,
        "failed_checks": [],
        "liquidity_ok": true,
        "price_ok": true,
        "no_trading_halts": true,
        "no_pending_ma": true,
        "earnings_clear": true
      },
      "composite_score": 0.11715506715506717,
      "news_summary": "CrowdStrike (CRWD) is gaining attention from analysts, with BTIG and Citizens both reiterating Buy ratings and suggesting significant upside potential, with price targets of $640 and $550, respectively. The company is expanding its capabilities through the acquisition of identity-security specialist SGNL for $740 million and achieving ISO/IEC 42001:2023 certification for responsible AI in cybersecurity. As it prepares to release its fourth-quarter earnings, analysts anticipate a strong performance, despite a recent pullback in stock price. Overall, CrowdStrike's strategic moves position it well within the growing cybersecurity and AI markets.",
      "price": 456.88,
      "market_cap": 115178729328.0,
      "scored_at": "2026-01-23T11:30:59.033544"
    },
    {
      "ticker": "CAT",
      "sector": "Industrials",
      "theme": "Regulatory Changes and Trade Policies",
      "factor_scores": {
        "value": 0.5,
        "quality": 0.7,
        "growth": -0.5,
        "stability": -0.5,
        "revisions": 0.42000000000000004,
        "momentum": -0.19044160820791697
      },
      "sentiment": {
        "overall_sentiment": "bullish",
        "sentiment_score": 0.4,
        "analyst_consensus": "Hold",
        "analyst_score": 0.2,
        "news_sentiment": "bullish",
        "news_score": 0.4,
        "key_drivers": [
          "Positive market forecast for mining drill bits indicating strong demand for Caterpillar's products.",
          "Recent share price momentum suggests strong investor interest.",
          "Majority of analysts recommend holding or buying, indicating confidence in the stock."
        ],
        "key_risks": [
          "Analysts predict a decline in earnings, which could impact stock performance.",
          "High current price relative to technical indicators may indicate overvaluation.",
          "Limited number of sell recommendations could suggest a lack of strong bearish sentiment."
        ],
        "price_target_upside": -4.903828670361203
      },
      "risk_flags": {
        "passed_all_checks": true,
        "failed_checks": [],
        "liquidity_ok": true,
        "price_ok": true,
        "no_trading_halts": true,
        "no_pending_ma": true,
        "earnings_clear": true
      },
      "composite_score": 0.11371556779274294,
      "news_summary": "Caterpillar (CAT) has seen a notable increase in its share price, rising 2.6% in a single day and 10.8% over the past month, with a current trading price of $645.38. However, analysts are cautious as they anticipate a decline in earnings in the upcoming report, indicating potential challenges ahead. Despite recent gains, CAT's performance has underperformed compared to competitors, raising questions about its valuation and future prospects. The broader market trends, including rising demand for battery metals and automation in mining, may influence CAT's business outlook moving forward.",
      "price": 632.465,
      "market_cap": 296296508753.0,
      "scored_at": "2026-01-23T11:27:34.739524"
    },
    {
      "ticker": "AMZN",
      "sector": "Consumer Discretionary",
      "theme": "AI Infrastructure Buildout",
      "factor_scores": {
        "value": -0.09999999999999999,
        "quality": 0.4,
        "growth": 0.5,
        "stability": -0.2,
        "revisions": 1.0,
        "momentum": 0.05772594956195603
      },
      "sentiment": {
        "overall_sentiment": "neutral",
        "sentiment_score": 0.1,
        "analyst_consensus": "Buy",
        "analyst_score": 0.8,
        "news_sentiment": "bearish",
        "news_score": -0.2,
        "key_drivers": [
          "Strong analyst consensus with 92.9% recommending 'Buy'",
          "Positive technical indicators with RSI at 55.6 indicating potential upward momentum"
        ],
        "key_risks": [
          "Recent job cuts of 14k corporate positions could impact morale and productivity",
          "Bearish news sentiment with three negative headlines outweighing positive ones"
        ],
        "price_target_upside": -38.64927121394047
      },
      "risk_flags": {
        "passed_all_checks": true,
        "failed_checks": [],
        "liquidity_ok": true,
        "price_ok": true,
        "no_trading_halts": true,
        "no_pending_ma": true,
        "earnings_clear": true
      },
      "composite_score": 0.07417742616961698,
      "news_summary": "Amazon (AMZN) is set to cut approximately 14,000 corporate jobs as part of a broader strategy to streamline operations ahead of its earnings report on February 5. This follows earlier reports of a total of 30,000 job cuts, raising concerns about the company's workforce strategy amidst its plans to expand product offerings. Analysts are adjusting their price targets for Amazon, reflecting evolving views on its business segments and associated risks. Despite these challenges, some analysts suggest that there remains significant growth potential for the company.",
      "price": 239.9401,
      "market_cap": 2565011331943.0,
      "scored_at": "2026-01-23T11:24:35.363442"
    },
    {
      "ticker": "CRM",
      "sector": "Information Technology",
      "theme": null,
      "factor_scores": {
        "value": -0.06666666666666665,
        "quality": 0.35,
        "growth": 0.2,
        "stability": -0.2,
        "revisions": 0.7976744186046512,
        "momentum": -0.14808946744886473
      },
      "sentiment": {
        "overall_sentiment": "bullish",
        "sentiment_score": 0.7,
        "analyst_consensus": "Buy",
        "analyst_score": 0.7,
        "news_sentiment": "bullish",
        "news_score": 0.8,
        "key_drivers": [
          "Strong analyst consensus with 69.8% recommending 'Buy'",
          "Positive news regarding AI advancements and market performance",
          "Recent bullish articles highlighting Salesforce's potential growth"
        ],
        "key_risks": [
          "Current RSI indicates potential oversold conditions at 35.7",
          "Market volatility affecting tech stocks",
          "Dependence on successful AI integration and market adoption"
        ],
        "price_target_upside": -29.393186966370443
      },
      "risk_flags": {
        "passed_all_checks": true,
        "failed_checks": [],
        "liquidity_ok": true,
        "price_ok": true,
        "no_trading_halts": true,
        "no_pending_ma": true,
        "earnings_clear": true
      },
      "composite_score": 0.0681234620520843,
      "news_summary": "Salesforce (CRM) is actively enhancing its platform with the integration of AI technologies, particularly through its Agentforce initiative, which aims to embed AI into workflows. Recent launches, including healthcare-focused AI services from Viz.ai and Ellipsis Health, highlight this strategic shift. Additionally, Salesforce's stock has shown positive momentum, closing at $228.09 with a 2.94% increase, surpassing market returns. These developments suggest a strong positioning for Salesforce in the evolving AI landscape, potentially attracting investor interest.",
      "price": 229.56,
      "market_cap": 218541123903.0,
      "scored_at": "2026-01-23T11:26:58.762473"
    },
    {
      "ticker": "SBUX",
      "sector": "Consumer Discretionary",
      "theme": null,
      "factor_scores": {
        "value": -0.3,
        "quality": 0.0,
        "growth": 0.0,
        "stability": 0.4,
        "revisions": 0.4235294117647058,
        "momentum": 0.4064822755860489
      },
      "sentiment": {
        "overall_sentiment": "neutral",
        "sentiment_score": 0.1,
        "analyst_consensus": "Hold",
        "analyst_score": 0.1,
        "news_sentiment": "neutral",
        "news_score": 0.0,
        "key_drivers": [
          "Positive outlook from 2026 Investor Day overhaul",
          "Strong technical indicators with high RSI",
          "Majority of analysts recommend holding"
        ],
        "key_risks": [
          "Bearish sentiment from recent earnings anticipation",
          "High number of hold recommendations indicating uncertainty",
          "Potential competition from other stocks"
        ],
        "price_target_upside": 9.03324808184143
      },
      "risk_flags": {
        "passed_all_checks": true,
        "failed_checks": [],
        "liquidity_ok": true,
        "price_ok": true,
        "no_trading_halts": true,
        "no_pending_ma": true,
        "earnings_clear": true
      },
      "composite_score": 0.05493052852930766,
      "news_summary": "Starbucks (SBUX) is set to unveil its long-term growth strategy at its 2026 Investor Day on January 29, 2026, under new CEO Brian Niccol, who aims to enhance store-level experiences amid competitive pressures. As the company approaches its Q1 earnings report, analysts are projecting stabilizing traffic and rising sales, although concerns about declining EPS and high costs persist. Recent trends indicate a significant rally in SBUX stock this year, suggesting potential investor optimism ahead of the earnings release. However, the company faces challenges, including competition from emerging chains and headwinds in the Chinese market.",
      "price": 97.75,
      "market_cap": 111151525000.0,
      "scored_at": "2026-01-23T11:28:14.230966"
    },
    {
      "ticker": "NUE",
      "sector": "Materials",
      "theme": "Regulatory Changes and Trade Policies",
      "factor_scores": {
        "value": 0.4666666666666667,
        "quality": 0.0,
        "growth": -0.5,
        "stability": -0.5,
        "revisions": 0.85,
        "momentum": 0.324436943379675
      },
      "sentiment": {
        "overall_sentiment": "bullish",
        "sentiment_score": 0.6,
        "analyst_consensus": "Buy",
        "analyst_score": 0.75,
        "news_sentiment": "neutral",
        "news_score": 0.0,
        "key_drivers": [
          "Strong analyst consensus with 75% Buy recommendations",
          "Positive technical indicators with SMA20 above SMA50 and RSI at 72",
          "Bullish news headline discussing a strong bull case for Nucor"
        ],
        "key_risks": [
          "Recent underperformance compared to competitors despite daily gains",
          "Bearish sentiment in some news articles regarding upcoming earnings",
          "Potential market volatility affecting industrial metals sector"
        ],
        "price_target_upside": -3.847847627435874
      },
      "risk_flags": {
        "passed_all_checks": true,
        "failed_checks": [],
        "liquidity_ok": true,
        "price_ok": true,
        "no_trading_halts": true,
        "no_pending_ma": true,
        "earnings_clear": true
      },
      "composite_score": 0.05485545519390437,
      "news_summary": "Nucor Corporation (NUE) is preparing to report its fourth-quarter earnings amid pressures from weaker segment performance, with analysts adjusting their estimates in light of mixed ratings and a generally improving outlook for 2026. Despite recent daily gains, NUE has underperformed compared to competitors, reflecting cautious sentiment in the market. The company is expected to benefit from a strong backlog in sectors like data centers and infrastructure, although near-term guidance remains uncertain. Overall, while there are bullish sentiments surrounding NUE, the stock faces challenges that investors should consider.",
      "price": 181.66,
      "market_cap": 41574526778.0,
      "scored_at": "2026-01-23T11:30:32.928196"
    },
    {
      "ticker": "AMD",
      "sector": "Information Technology",
      "theme": "AI Infrastructure Buildout",
      "factor_scores": {
        "value": -0.39999999999999997,
        "quality": -0.25,
        "growth": 0.5,
        "stability": -0.5,
        "revisions": 0.7904761904761904,
        "momentum": 1.0
      },
      "sentiment": {
        "overall_sentiment": "neutral",
        "sentiment_score": 0.1,
        "analyst_consensus": "Buy",
        "analyst_score": 0.7,
        "news_sentiment": "bearish",
        "news_score": -0.6,
        "key_drivers": [
          "Strong analyst consensus with 69% Buy recommendations",
          "Positive technical indicators with high RSI",
          "Recent bullish news regarding stock performance"
        ],
        "key_risks": [
          "Negative news sentiment with multiple bearish headlines",
          "Intel's poor performance impacting market perception",
          "Potential supply chain issues affecting the semiconductor industry"
        ],
        "price_target_upside": 11.95570643138287
      },
      "risk_flags": {
        "passed_all_checks": true,
        "failed_checks": [],
        "liquidity_ok": true,
        "price_ok": true,
        "no_trading_halts": true,
        "no_pending_ma": true,
        "earnings_clear": true
      },
      "composite_score": 0.049092970521541934,
      "news_summary": "Advanced Micro Devices (AMD) saw its stock rise amid Intel's significant struggles, including a 12% drop in share price due to disappointing earnings and supply chain issues affecting its data-center chip production. As Intel's challenges mount, AMD may benefit from increased market share in the semiconductor space, particularly in AI-driven demand. The overall market sentiment was impacted by Intel's outlook, contributing to fluctuations in major indices like the Dow and Nasdaq. Investors are closely monitoring AMD's performance as it navigates this competitive landscape.",
      "price": 258.638,
      "market_cap": 421073009520.0,
      "scored_at": "2026-01-23T11:26:47.553458"
    },
    {
      "ticker": "BRK.B",
      "sector": "Financials",
      "theme": null,
      "factor_scores": {
        "value": 0.4666666666666667,
        "quality": 0.09999999999999998,
        "growth": -0.5,
        "stability": 0.5,
        "revisions": -0.2857142857142857,
        "momentum": -0.06419121137691208
      },
      "sentiment": {
        "overall_sentiment": "neutral",
        "sentiment_score": 0.0,
        "analyst_consensus": "Hold",
        "analyst_score": 0.0,
        "news_sentiment": "neutral",
        "news_score": 0.0,
        "key_drivers": [
          "Positive sentiment from portfolio strategies for early retirees",
          "Bullish perspectives on portfolio building"
        ],
        "key_risks": [
          "Concerns over Berkshire's potential exit from Kraft Heinz",
          "Bearish outlook on market reliance on specific trades"
        ],
        "price_target_upside": null
      },
      "risk_flags": {
        "passed_all_checks": true,
        "failed_checks": [],
        "liquidity_ok": true,
        "price_ok": true,
        "no_trading_halts": true,
        "no_pending_ma": true,
        "earnings_clear": true
      },
      "composite_score": 0.03481175637434206,
      "news_summary": "Berkshire Hathaway is reportedly preparing to sell its $7 billion stake in Kraft Heinz, a move that has caused Kraft Heinz's shares to drop approximately 6%. This decision, attributed to new CEO Greg Abel's desire to move on from a deal viewed as a misstep by Warren Buffett, reflects a shift in Berkshire's investment strategy amid a changing economic landscape. Analysts have rated BRK.A stock as a Hold, indicating caution as the company navigates a less favorable market environment.",
      "price": 481.38,
      "market_cap": 1044972.1811719409,
      "scored_at": "2026-01-23T11:25:02.591837"
    },
    {
      "ticker": "ILMN",
      "sector": "Health Care",
      "theme": null,
      "factor_scores": {
        "value": 0.7,
        "quality": 0.05000000000000002,
        "growth": -0.5,
        "stability": -0.2,
        "revisions": 0.3222222222222222,
        "momentum": 0.3842624455150257
      },
      "sentiment": {
        "overall_sentiment": "bullish",
        "sentiment_score": 0.7,
        "analyst_consensus": "Hold",
        "analyst_score": 0.2,
        "news_sentiment": "bullish",
        "news_score": 0.6,
        "key_drivers": [
          "Positive growth outlook for whole genome sequencing market",
          "Recent bullish analyst shifts",
          "Strong technical indicators with RSI indicating potential upward momentum"
        ],
        "key_risks": [
          "Majority of analysts recommend holding rather than buying",
          "Potential market volatility affecting stock performance",
          "High current price compared to historical averages"
        ],
        "price_target_upside": -18.1578947368421
      },
      "risk_flags": {
        "passed_all_checks": true,
        "failed_checks": [],
        "liquidity_ok": true,
        "price_ok": true,
        "no_trading_halts": true,
        "no_pending_ma": true,
        "earnings_clear": true
      },
      "composite_score": -0.010537767144787153,
      "news_summary": "Illumina (NASDAQ: ILMN) has recently secured reimbursement for its TruSight™ Oncology Comprehensive test, enhancing access to precision oncology and genomic profiling. Analysts have raised the company's price target, reflecting optimism about recovering end markets and new partnerships, including a significant alliance with AstraZeneca, Merck, and Eli Lilly for large-scale genomics. The global market for whole genome sequencing is projected to grow, driven by advancements in technology and increased demand for precision medicine, which bodes well for Illumina's future prospects.",
      "price": 152.0,
      "market_cap": 23225600000.0,
      "scored_at": "2026-01-23T11:29:47.271882"
    },
    {
      "ticker": "AMCR",
      "sector": "Materials",
      "theme": "Inflation Hedge Investments",
      "factor_scores": {
        "value": 0.0,
        "quality": -0.25,
        "growth": 0.5,
        "stability": 0.7,
        "revisions": 0.7923076923076923,
        "momentum": -0.06416062801932298
      },
      "sentiment": {
        "overall_sentiment": "neutral",
        "sentiment_score": 0.0,
        "analyst_consensus": "Buy",
        "analyst_score": 0.5,
        "news_sentiment": "neutral",
        "news_score": 0.0,
        "key_drivers": [
          "Strong analyst consensus with 69.2% recommending a buy",
          "Positive technical indicators with RSI at 58.4 indicating potential upward momentum",
          "Current price is significantly above the price target suggesting potential for correction"
        ],
        "key_risks": [
          "Lack of bullish news sentiment with all recent headlines being neutral",
          "Potential market volatility affecting stock performance",
          "Concerns regarding the implications of the reverse split on investor perception"
        ],
        "price_target_upside": -73.71181030551756
      },
      "risk_flags": {
        "passed_all_checks": true,
        "failed_checks": [],
        "liquidity_ok": true,
        "price_ok": true,
        "no_trading_halts": true,
        "no_pending_ma": true,
        "earnings_clear": true
      },
      "composite_score": -0.015692630638282794,
      "news_summary": "Amcor plc (AMCR) recently completed a 1-for-5 reverse stock split, which has reshaped its equity structure and may influence investor perceptions. Despite a recent 2.99% gain in one day, the stock has shown mixed performance with a year-to-date return of only 0.83% and declines of 7.64% and 15.85% over the past year and three years, respectively. The company is set to report its fiscal 2026 second quarter results on February 3, 2026, which could provide further insights into its financial health and market position.",
      "price": 43.86,
      "market_cap": 20248933394.0,
      "scored_at": "2026-01-23T11:30:00.266629"
    },
    {
      "ticker": "DIS",
      "sector": "Communication Services",
      "theme": "Consumer Sentiment Recovery",
      "factor_scores": {
        "value": 0.5,
        "quality": 0.2,
        "growth": 0.0,
        "stability": -0.2,
        "revisions": 0.7296296296296295,
        "momentum": -0.14071363489404168
      },
      "sentiment": {
        "overall_sentiment": "neutral",
        "sentiment_score": -0.1,
        "analyst_consensus": "Buy",
        "analyst_score": 0.5,
        "news_sentiment": "bearish",
        "news_score": -0.5,
        "key_drivers": [
          "Strong analyst consensus with 66.7% Buy recommendations",
          "Price target indicates potential for upside"
        ],
        "key_risks": [
          "Negative news regarding leadership changes and competition",
          "Recent bearish sentiment in news articles"
        ],
        "price_target_upside": -37.116866822011104
      },
      "risk_flags": {
        "passed_all_checks": true,
        "failed_checks": [],
        "liquidity_ok": true,
        "price_ok": true,
        "no_trading_halts": true,
        "no_pending_ma": true,
        "earnings_clear": true
      },
      "composite_score": -0.01816449407784682,
      "news_summary": "Disney is set to appoint a new CEO in early 2026, a critical move aimed at revitalizing its stagnant stock performance, which has seen little growth over the past decade. The company is also facing challenges as traditional cable subscriptions decline, with projections indicating that 75% of U.S. households will cut the cord by the end of 2026. Additionally, Jim Cramer has noted a price target cut for Disney shares, which have only risen modestly by 1.2% over the past year. Analysts suggest that leveraging AI could be a potential strategy for Disney to turn its fortunes around.",
      "price": 111.58,
      "market_cap": 200613454743.0,
      "scored_at": "2026-01-23T11:25:27.529176"
    },
    {
      "ticker": "NKE",
      "sector": "Consumer Discretionary",
      "theme": null,
      "factor_scores": {
        "value": -0.09999999999999999,
        "quality": 0.0,
        "growth": -0.5,
        "stability": -0.2,
        "revisions": 0.50625,
        "momentum": 0.020643030396861817
      },
      "sentiment": {
        "overall_sentiment": "bullish",
        "sentiment_score": 0.3,
        "analyst_consensus": "Buy",
        "analyst_score": 0.4,
        "news_sentiment": "bearish",
        "news_score": -0.2,
        "key_drivers": [
          "Positive changes in investment strategy with 'Win Now' overhaul",
          "Appointment of experienced executives to the board"
        ],
        "key_risks": [
          "Concerns about limited room for error in current market conditions",
          "Skepticism about Nike's ability to regain past performance"
        ],
        "price_target_upside": 16.44259001699892
      },
      "risk_flags": {
        "passed_all_checks": true,
        "failed_checks": [],
        "liquidity_ok": true,
        "price_ok": true,
        "no_trading_halts": true,
        "no_pending_ma": true,
        "earnings_clear": true
      },
      "composite_score": -0.04127890331443516,
      "news_summary": "Nike (NKE) is undergoing a significant transformation under CEO Elliott Hill, focusing on leadership changes and a shift towards a more balanced wholesale and direct-to-consumer sales model. Despite this strategic overhaul, recent Q2 results revealed flat revenue and a 32% year-over-year decline in earnings per share, raising concerns about the company's competitive position. The stock has experienced volatility, with a recent price of around $63.63, reflecting mixed performance trends that could impact investor sentiment. Overall, analysts are cautious, suggesting that Nike faces challenges in regaining its former market strength.",
      "price": 64.71,
      "market_cap": 95629924971.0,
      "scored_at": "2026-01-23T11:27:57.994628"
    },
    {
      "ticker": "ENPH",
      "sector": "Utilities",
      "theme": "Energy Transition and Sustainability",
      "factor_scores": {
        "value": -0.06666666666666665,
        "quality": 0.0,
        "growth": -0.5,
        "stability": -0.2,
        "revisions": 0.07142857142857145,
        "momentum": 1.0
      },
      "sentiment": {
        "overall_sentiment": "bullish",
        "sentiment_score": 0.6,
        "analyst_consensus": "Hold",
        "analyst_score": 0.1,
        "news_sentiment": "bullish",
        "news_score": 0.5,
        "key_drivers": [
          "Recent surge of 12.5% indicates strong market interest",
          "Positive outlook on tailwinds overshadowing headwinds",
          "Recognition as a top short squeeze candidate"
        ],
        "key_risks": [
          "Majority of analysts recommend holding rather than buying",
          "High RSI indicates potential overbought conditions",
          "Market volatility could impact future performance"
        ],
        "price_target_upside": -3.406379255488395
      },
      "risk_flags": {
        "passed_all_checks": true,
        "failed_checks": [],
        "liquidity_ok": true,
        "price_ok": true,
        "no_trading_halts": true,
        "no_pending_ma": true,
        "earnings_clear": true
      },
      "composite_score": -0.05173148695261345,
      "news_summary": "Enphase Energy (ENPH) has recently gained attention, surging 12.5% amid higher trading volumes, suggesting potential for further gains driven by positive earnings estimate revisions. The company is focusing on operational discipline, tightening inventory, and emphasizing cash generation to navigate near-term challenges in the solar market. Analysts suggest that despite current headwinds, ENPH may be undervalued with key catalysts on the horizon, making it a stock to watch for potential rebounds in late 2026.",
      "price": 40.2304,
      "market_cap": 5264538437.0,
      "scored_at": "2026-01-23T11:30:38.369715"
    },
    {
      "ticker": "BA",
      "sector": "Industrials",
      "theme": null,
      "factor_scores": {
        "value": -0.6,
        "quality": -0.4,
        "growth": -0.5,
        "stability": 0.1,
        "revisions": 0.85,
        "momentum": 0.10663060735717511
      },
      "sentiment": {
        "overall_sentiment": "bullish",
        "sentiment_score": 0.7,
        "analyst_consensus": "Buy",
        "analyst_score": 0.75,
        "news_sentiment": "bullish",
        "news_score": 0.6,
        "key_drivers": [
          "Strong analyst consensus with 75% Buy recommendations",
          "Positive news regarding Boeing's order gains and foreign contracts",
          "High RSI indicating strong momentum"
        ],
        "key_risks": [
          "Caution advised before earnings as per one bearish news article",
          "Market volatility could impact stock performance",
          "Potential geopolitical risks affecting defense contracts"
        ],
        "price_target_upside": 1.2022250134577486
      },
      "risk_flags": {
        "passed_all_checks": true,
        "failed_checks": [],
        "liquidity_ok": true,
        "price_ok": true,
        "no_trading_halts": true,
        "no_pending_ma": true,
        "earnings_clear": true
      },
      "composite_score": -0.10920806631632499,
      "news_summary": "Boeing stock has seen a significant rise ahead of its Q4 earnings report, with investors optimistic about the company's future prospects. The U.S. aerospace sector is benefiting from a surge in foreign government procurement contracts, largely attributed to Boeing's order gains, which totaled $244 billion in 2025. Additionally, upcoming earnings on January 27 could further influence stock performance, as analysts suggest caution amidst the positive momentum. Overall, the aerospace industry is poised for growth, supported by favorable economic conditions and increasing demand for air travel.",
      "price": 250.785,
      "market_cap": 196382460735.0,
      "scored_at": "2026-01-23T11:27:28.851018"
    },
    {
      "ticker": "TSLA",
      "sector": "Consumer Discretionary",
      "theme": "Energy Transition and Sustainability",
      "factor_scores": {
        "value": -0.5,
        "quality": -0.25,
        "growth": 0.0,
        "stability": -0.5,
        "revisions": 0.32000000000000006,
        "momentum": 0.18753961739289063
      },
      "sentiment": {
        "overall_sentiment": "neutral",
        "sentiment_score": 0.1,
        "analyst_consensus": "Hold",
        "analyst_score": 0.0,
        "news_sentiment": "neutral",
        "news_score": 0.0,
        "key_drivers": [
          "Positive commentary from Michael O'Leary regarding Tesla's publicity",
          "Strong analyst price target indicating potential for growth"
        ],
        "key_risks": [
          "Bearish sentiment surrounding Q4 earnings preview",
          "Mixed analyst recommendations with a significant hold rating"
        ],
        "price_target_upside": 3.9078100422797704
      },
      "risk_flags": {
        "passed_all_checks": true,
        "failed_checks": [],
        "liquidity_ok": true,
        "price_ok": true,
        "no_trading_halts": true,
        "no_pending_ma": true,
        "earnings_clear": true
      },
      "composite_score": -0.1486885896479576,
      "news_summary": "Tesla is set to report its Q4 earnings next week, with analysts closely monitoring key metrics beyond headline estimates amid a challenging market environment. The company has begun testing driverless robotaxi rides in Austin, removing in-car safety monitors, which reflects its commitment to advancing its Full Self-Driving (FSD) technology. Additionally, Morgan Stanley anticipates that Tesla's FSD rollout in China could significantly benefit the local autonomous-driving supply chain, although recent news indicates that the company's ambitious plans may still be far from realization, potentially impacting investor returns.",
      "price": 448.205,
      "market_cap": 1490648779745.0,
      "scored_at": "2026-01-23T11:24:51.795305"
    },
    {
      "ticker": "TGT",
      "sector": "Consumer Discretionary",
      "theme": "Consumer Sentiment Recovery",
      "factor_scores": {
        "value": 0.36666666666666664,
        "quality": 0.0,
        "growth": -0.5,
        "stability": 0.1,
        "revisions": 0.2142857142857143,
        "momentum": -0.25383184858573976
      },
      "sentiment": {
        "overall_sentiment": "neutral",
        "sentiment_score": 0.1,
        "analyst_consensus": "Hold",
        "analyst_score": 0.1,
        "news_sentiment": "neutral",
        "news_score": 0.0,
        "key_drivers": [
          "Strong analyst support with a majority recommending Hold",
          "Recent appointment of experienced executives to the board"
        ],
        "key_risks": [
          "Current price is above the 50-day SMA, indicating potential overvaluation",
          "High percentage of Hold recommendations may indicate uncertainty"
        ],
        "price_target_upside": -8.864163189615196
      },
      "risk_flags": {
        "passed_all_checks": true,
        "failed_checks": [],
        "liquidity_ok": true,
        "price_ok": true,
        "no_trading_halts": true,
        "no_pending_ma": true,
        "earnings_clear": true
      },
      "composite_score": -0.1621075728187487,
      "news_summary": "Target Corporation (TGT) is facing challenges as employees protest against recent ICE actions in Minnesota, leading to staff absenteeism at several locations. The company is also preparing for a Q4 earnings report, with analysts predicting a significant decline in profits. In a positive development, Target has appointed two experienced retail executives to its Board of Directors, aiming to enhance its consumer-focused strategies. Additionally, the company has declared a quarterly dividend of $1.14, marking its 234th consecutive dividend payment since going public.",
      "price": 107.85,
      "market_cap": 49006945631.0,
      "scored_at": "2026-01-23T11:28:37.948950"
    },
    {
      "ticker": "Z",
      "sector": "Communication Services",
      "theme": "Small-Cap Growth Surge",
      "factor_scores": {
        "value": -0.09999999999999998,
        "quality": -0.4,
        "growth": 0.5,
        "stability": -0.5,
        "revisions": 0.58,
        "momentum": 0.10433544459174084
      },
      "sentiment": {
        "overall_sentiment": "neutral",
        "sentiment_score": 0.0,
        "analyst_consensus": "Hold",
        "analyst_score": 0.0,
        "news_sentiment": "neutral",
        "news_score": 0.0,
        "key_drivers": [
          "Analyst consensus is balanced with a slight majority holding.",
          "Positive news regarding housing affordability in major markets.",
          "Some bullish sentiment from analysts despite recent downgrades."
        ],
        "key_risks": [
          "Recent bearish news indicating potential dominance issues.",
          "Concerns from bearish analyst theories.",
          "Market uncertainty affecting housing sector."
        ],
        "price_target_upside": -34.59302325581395
      },
      "risk_flags": {
        "passed_all_checks": true,
        "failed_checks": [],
        "liquidity_ok": true,
        "price_ok": true,
        "no_trading_halts": true,
        "no_pending_ma": true,
        "earnings_clear": true
      },
      "composite_score": -0.1969364074003933,
      "news_summary": "Zillow Group has faced recent challenges, including a downgrade from Mizuho due to ongoing legal concerns and uncertainties regarding its business model, particularly the Flex agent program. Despite these issues, Zillow's research indicates a significant opportunity in mortgage financing, as many borrowers still apply with only one lender. Additionally, forecasts suggest that home affordability is improving in major markets, which could positively impact Zillow's business. However, analysts have trimmed Zillow's price target amid concerns about legal risks and revenue growth, reflecting a cautious outlook on the company's future performance.",
      "price": 68.8,
      "market_cap": 16652077557.0,
      "scored_at": "2026-01-23T11:31:05.679377"
    },
    {
      "ticker": "INTC",
      "sector": "Information Technology",
      "theme": "AI Infrastructure Buildout",
      "factor_scores": {
        "value": -0.3,
        "quality": -0.4,
        "growth": -0.5,
        "stability": -0.2,
        "revisions": 0.054545454545454564,
        "momentum": -0.5182464128035325
      },
      "sentiment": {
        "overall_sentiment": "neutral",
        "sentiment_score": 0.1,
        "analyst_consensus": "Hold",
        "analyst_score": 0.1,
        "news_sentiment": "neutral",
        "news_score": 0.0,
        "key_drivers": [
          "Recent bullish news regarding competitors may indicate a positive market environment.",
          "Technical indicators show a stable RSI suggesting no immediate overbought or oversold conditions."
        ],
        "key_risks": [
          "Concerns over Intel's demand issues impacting overall performance.",
          "Recent bearish news could affect investor sentiment."
        ],
        "price_target_upside": 2.976949939736956
      },
      "risk_flags": {
        "passed_all_checks": true,
        "failed_checks": [],
        "liquidity_ok": true,
        "price_ok": true,
        "no_trading_halts": true,
        "no_pending_ma": true,
        "earnings_clear": true
      },
      "composite_score": -0.27186454779583924,
      "news_summary": "Intel (INTC) has faced significant challenges, with its stock declining following disappointing first quarter guidance that failed to meet Wall Street expectations, despite reporting fourth quarter earnings that exceeded revenue and EPS estimates. The company is struggling to meet AI data center demands, which has raised concerns about its future performance and market share. Analysts suggest that Intel's transparency regarding these issues is a positive sign, but the immediate outlook remains bleak, impacting investor sentiment and contributing to broader market declines. Meanwhile, competitors like AMD may benefit from Intel's struggles as they capitalize on the shifting demand landscape.",
      "price": 45.3014,
      "market_cap": 216087678000.0,
      "scored_at": "2026-01-23T11:26:41.746242"
    },
    {
      "ticker": "MRNA",
      "sector": "Health Care",
      "theme": "Health and Biotech Innovation",
      "factor_scores": {
        "value": -0.6,
        "quality": -0.4,
        "growth": -0.5,
        "stability": 0.1,
        "revisions": 0.1,
        "momentum": 1.0
      },
      "sentiment": {
        "overall_sentiment": "bullish",
        "sentiment_score": 0.6,
        "analyst_consensus": "Hold",
        "analyst_score": 0.2,
        "news_sentiment": "bullish",
        "news_score": 0.8,
        "key_drivers": [
          "Positive news on personalized cancer therapy results",
          "Recent bullish trends in the healthcare sector",
          "Strong performance of major indices"
        ],
        "key_risks": [
          "High RSI indicating potential overbought conditions",
          "Majority of analysts recommending a Hold",
          "Market volatility affecting stock performance"
        ],
        "price_target_upside": -36.89782910461859
      },
      "risk_flags": {
        "passed_all_checks": true,
        "failed_checks": [],
        "liquidity_ok": true,
        "price_ok": true,
        "no_trading_halts": true,
        "no_pending_ma": true,
        "earnings_clear": true
      },
      "composite_score": -0.3428571428571428,
      "news_summary": "Moderna (MRNA) shares have surged to a 52-week high of $50, driven by promising results from a five-year phase IIb study of its personalized cancer therapy, which showed a 49% reduction in recurrence or death risk for high-risk melanoma patients. The stock's rally is part of a broader optimism on Wall Street regarding Moderna's pipeline of cancer drugs, especially as its respiratory vaccine business faces challenges. Additionally, the YieldMax MRNA Option Income Strategy ETF has seen increased distributions in line with MRNA's share price resurgence. However, CEO Stephane Bancel indicated that the company will not pursue late-stage vaccine trials due to heightened scrutiny from U.S. officials.",
      "price": 48.6988,
      "market_cap": 19028259193.0,
      "scored_at": "2026-01-23T11:31:24.637472"
    },
    {
      "ticker": "FSLY",
      "sector": "Information Technology",
      "theme": "Small-Cap Growth Surge",
      "factor_scores": {
        "value": -0.6,
        "quality": -0.4,
        "growth": 0.2,
        "stability": 0.4,
        "revisions": 0.023076923076923078,
        "momentum": 0.15348964013086216
      },
      "sentiment": {
        "overall_sentiment": "bearish",
        "sentiment_score": -0.6,
        "analyst_consensus": "Hold",
        "analyst_score": -0.1,
        "news_sentiment": "bearish",
        "news_score": -0.8,
        "key_drivers": [],
        "key_risks": [
          "Recent insider selling by key executives",
          "Negative comparisons with competitors like Cloudflare",
          "High percentage of Hold and Sell recommendations from analysts"
        ],
        "price_target_upside": -39.742903053026254
      },
      "risk_flags": {
        "passed_all_checks": true,
        "failed_checks": [],
        "liquidity_ok": true,
        "price_ok": true,
        "no_trading_halts": true,
        "no_pending_ma": true,
        "earnings_clear": true
      },
      "composite_score": -0.4000169768435853,
      "news_summary": "Fastly's CTO, Artur Bergman, recently sold a total of 60,000 shares in two transactions, raising concerns among investors regarding insider confidence as the stock trades around $10. The company is set to announce its fourth quarter and full year 2025 financial results on February 11, 2026, which could provide further insights into its performance amidst increasing competition from rivals like Cloudflare. Despite a recent uptick of 4.2% in stock price, Fastly remains down 10.2% over the past month and has experienced a significant decline of 88.5% over the last five years, prompting discussions about its valuation and long-term prospects in the edge computing market.",
      "price": 9.335,
      "market_cap": 1394649000.0,
      "scored_at": "2026-01-23T11:30:51.331402"
    },
    {
      "ticker": "SLV",
      "sector": "Materials",
      "theme": "Geopolitical Risk and Safe Havens",
      "factor_scores": {
        "value": -0.6,
        "quality": -0.5,
        "growth": -0.5,
        "stability": -0.2,
        "revisions": 0.1,
        "momentum": 0.8141302608417349
      },
      "sentiment": {
        "overall_sentiment": "neutral",
        "sentiment_score": 0.0,
        "analyst_consensus": "Hold",
        "analyst_score": 0.0,
        "news_sentiment": "neutral",
        "news_score": 0.0,
        "key_drivers": [
          "Recent upgrade by Analyst A indicating potential for positive movement",
          "Bullish news regarding short squeeze in AI race"
        ],
        "key_risks": [
          "Downgrade by Analyst B suggesting caution",
          "Bearish news on divergence of silver prices in U.S. and China"
        ],
        "price_target_upside": -75.39370078740157
      },
      "risk_flags": {
        "passed_all_checks": true,
        "failed_checks": [],
        "liquidity_ok": true,
        "price_ok": true,
        "no_trading_halts": true,
        "no_pending_ma": true,
        "earnings_clear": true
      },
      "composite_score": -0.4898033209122983,
      "news_summary": "Recent developments in the silver market indicate a significant divergence in prices between the U.S. and China, with a notable gap of approximately $10 per ounce, suggesting differing market dynamics. Analysts are speculating that silver could see a rally, potentially reaching $120, driven by geopolitical factors such as a possible deal involving Greenland. Additionally, silver has been highlighted as one of the best-performing assets in the precious metals category, reflecting strong investor interest amid broader economic stability.",
      "price": 91.44,
      "market_cap": 52424868907.0,
      "scored_at": "2026-01-23T11:30:14.408821"
    }
  ],
  "scored_at": "2026-01-23T11:31:24.639346",
  "stats": {
    "total_scored": 70,
    "passed_risk_screens": 70,
    "avg_composite_score": 0.22572622859421299,
    "top_10_scores": [
      0.6496392757069107,
      0.6262914612538673,
      0.6175756716602525,
      0.5959070161962835,
      0.5702027577958263,
      0.5234934065154372,
      0.5226041375242085,
      0.5165747755057818,
      0.5117974602016009,
      0.49122330633284245
    ]
  }
}